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Abstract
A family history of diabetes (FH+) is considered a risk factor for the development of
insulin resistance and type 2 diabetes. However, it is not known whether exercise
induced improvement in insulin sensitivity (IS) and metabolic flexibility (MF) are
impacted by a FH+. Purpose: To determine if a FH+ limits exercise induced
improvements in Insulin sensitivity, MF, body composition, and strength following an 8week combined aerobic and resistance training intervention compared to those without
a family history of diabetes (FH-). Methods: 19 (FH- n=9, age 21.89 ± 0.60 years, BMI
27.51 ± 1.68 kg/m2; FH+ n=10, age 23.41 ± 0.86 years, BMI 26.64 ± 1.02 kg/m2)
sedentary, normoglycemic, Mexican-American males underwent 8-weeks of combined
exercise training 3 times/week (35-min aerobic & 45-min resistance training/session). A
controlled diet (55/15/30% Cho/Pro/Fat) was provided 5 days before pre/post
intervention tests. Insulin sensitivity was assessed by hyperinsulinemic euglycemic
clamp. MF was assessed by change in respiratory quotient (ΔRQ) at the insulin
stimulated state of the clamp compared to the fasted state. Body composition was
measured using DXA. Upper and lower body strength were measured by 1 repetition
maximum bench press and leg strength dynamometer respectively. Results: Insulin
sensitivity significantly improved after 8 weeks of combined exercise training in both
groups (FH- 2.99 ± 0.27 to 3.89 ± 0.28 ml/kg estimated metabolic body size (EMBS),
p=0.02; FH+ 3.63 ± 0.50 to 4.82 ± 0.51 ml/kg EMBS; p=0.002). MF did not change (FH0.07 ± 0.01 to 0.09 ± 0.01, p=0.71; FH+ 0.08 ± 0.01 to 0.11 ± 0.02, p=0.24). Fat free
mass significantly increased in both groups (FH- 54.82 ± 2.28 to 56.52 ± 1.87 kg,
p=0.02, FH+ 51.14 ± 1.58 to 53.42 ± 1.8 kg, p=0.001). Upper body strength (FH- 155.00
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± 20.83 to 181.10±21.13 lb, p=0.0001; FH+ 148.50 ± 16.87 to 178.00 ± 16.75 lb,
p=0.0001) and lower body strength (FH- 354.44 ± 31.97 to 416.67 ± 27.55 lb, p=0.0006;
FH+ 356.00 ± 20.18 to 419.50 ± 15.99 lb, p=0.0003) significantly increased in both
groups. Insulin sensitivity Improvement reported as percent (%) change were not
different between groups (FH- 34.90 ± 11.00 % vs. FH+ 40.66 ± 12.19 %; p>0.05).
Percent change in metabolic flexibility was not blunted by FH+ between groups at
baseline (FH- 9.97 ± 2.27 % vs. FH+ 10.72 ± 1.93 %; p>0.05) or post intervention (FH12.73 ± 2.69 % vs. 15.81 ± 3.05 %, p>0.05) Conclusion: FH+ was not indicative of a
lower insulin sensitivity compared to FH- in healthy young men. Additionally, FH+ is not
a limiting factor for exercise induced improvements in Insulin sensitivity, MF, body
composition, and strength in young normoglycemic Mexican-American men.
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Chapter 1: Introduction
Type 2 Diabetes
With prevalence rates more than doubling over the last two decades, Type 2
diabetes (T2D) has now become the 7th leading cause of death in the United States [1]
T2D can be diagnosed in the clinical setting by a fasting blood glucose level above 126
mg/dl [2]. T2D accounts for 90-95% of diabetes cases with a high prevalence in those
who are physically inactive, obese, have a family history of T2D (FH+) and are of old
age [1]. Additionally, the prevalence of T2D is greater in certain ethnic groups such as
non-Hispanic blacks (17.7% aged 18 and over) and Hispanics (16.4% aged 18 and
over) compared to Caucasians (9.3% aged 18 and over) [1]. It has also been shown
that Hispanics have a 51% greater risk for developing diabetes compared to nonHispanic white adults [1]. In addition to this, it has been demonstrated that those with a
FH+ have a greater risk for developing the disease, with a contribution from both
genetic and environmental factors [3].

Compromised Insulin Sensitivity with Family History of Type 2 Diabetes
The prevalence of T2D has been reported to be greater in the offspring of
parents with T2D, compared to non-diabetic parents [3-11] (Table 1.). (Appendix A).
Table 1. depicts relevant studies that investigated the effects of FH of T2D. As shown
by Perez-Fuentes et al., (2014) middle aged FH+ individuals had a lower insulin
sensitivity (IS), measured through quantitative insulin sensitivity check index (QUICKI)
as well as greater fasting insulin levels [12]. FH+ has been reported to have a
significantly lower glucose uptake capacity during insulin stimulated conditions
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(hyperinsulinemic euglycemic clamp) when compared to individuals without a family
history (FH-) of T2D [13]. Martin et al., (1992), examined glucose tolerant individuals for
25 years and found that 76% of individuals, who had lower insulin sensitivity during an
oral glucose tolerance test, developed T2D by the end of the 25 year follow up.

Table 1. Literature Overview- Effects of Family History of Type 2 Diabetes on Insulin
Sensitivity
Study

Status

Petersen et al.
2004

Insulin
Resistant &
Insulin
Sensitive
Normoglycemic

Method

Outcome

Age

Sex

One parent or
grandparent

HyperinsulinemicEuglycemic
Clamp

¯ IS in FH+

25-29

8m/18F

NA

First-degree
relative

Hyperinsulinemic
euglycemic clamp

¯ IS in FH+

19-41

28M/50F

White

HeilBronn et
al. 2007

Normoglycemic

First-degree
relative

Hyperinsulinemic
euglycemic clamp

No
Difference

34-52

5M/12F

White

Arslanian et al.
2005

Normoglycemic

First-degree
relative

Hyperinsulinemic
euglycemic clamp

¯ IS in FH+

11-12

25M/29F

White

Groop et al.
1996

Normoglycemic

First-degree
relative

Hyperinsulinemic
euglycemic clamp
& OGTT

35-65

46M/39F

Hispanic

Gulli et al.
1992

Normoglycemic

First-degree
relative

Hyperinsulinemic
euglycemic clamp
& OGTT

34-42

3M/18F

MexicanAmerican

Van Haeften et
al. 1998

Normoglycemic

First-degree
relative

44-47

8M/34F

White

Haffner et al.
1997

Normoglycemic
& Impaired
Glucose
Tolerance
Normoglycemic

First-degree
relative

Hyperglycemic
clamp
& OGTT
2-h OGTT

¯Glucose
tolerance
in FH+
¯ IS in FH+
No
Difference
in OGTT
¯ IS in FH+
No
Difference
¯Glucose
tolerance
in FH+

25-65

533M/743F

First-degree
relative

2-h OGTT

¯ IS in FH+

26-52

52M/36F

Normoglycemic
& Impaired
Glucose
Tolerance
Normoglycmic

First-degree
relative

2-h OGTT

¯Glucose
tolerance
in FH+

20+

First-degree
relative

2-h OGTT

¯ IS in FH+

16-60

71M/84F

NA

Osei et al.
1991

Normoglycemic

Family history of
diabetes

2-h OGTT
FSIVGTT

¯ IS in FH+

24-30

4M/16F

N/A

Wang et al.
2008

Normoglycemic
& Impaired
glucose
tolerance &
T2D
Normoglycemic

First-degree
relative

2-h OGTT
HOMA-IR

¯Glucose
tolerance
in FH+

31-65

183M/240F

Chinese

Relatives with
diabetes

HOMA-IR

¯ IS in FH+

18-68

66M/77F

Hispanic

Perseghin et
al. 1997

Ishikawa et al.
1998
Ramachandran
et al. 1997
Warram et al.
1990

Ryder et al.
2003

Family History

2

810M/936F

Race

Hispanics
&
African
Americans
White

Indian

Guerrero et al.
2005

Normoglycemic

Family history of
diabetes

HOMA-IR

¯ IS in FH+

18-24

18M/30F

White

Perez-Fuentes
et al. 2014

Normoglycemic

First-degree
relative

QUICKI

¯ IS in FH+

18-65

602 M&F

White

2-h OGTT: 2-hour Oral Glucose Tolerance Test; HOMA-IR: Homeostatic Model Assessment of Insulin Resistance.

Lower insulin sensitivity often precedes the development of T2D, and therefore,
can serve as an “early detection” in otherwise healthy normoglycemic individuals [14].
During the clinical and scientific setting there is often a tradeoff for employing the most
sensitive method for testing insulin sensitivity for the most feasible method as it is
primarily determined by the number of subjects, expertise, personnel, and funding.
Ryder et al., (2003) and Haffner et al., (1997) assessed insulin sensitivity through an
oral glucose tolerance test and demonstrated that healthy, middle aged, MexicanAmerican FH+ individuals had lower insulin sensitivity when compared to FHindividuals. The gold standard hyperinsulinemic-euglycemic clamp has been employed
in previous studies to assess insulin sensitivity in healthy, middle aged,
Mexican/Hispanic individuals and concluded that FH+ is associated with insulin
resistance [3, 13]. Although the clamp is the most sensitive method to measure insulin
sensitivity, its complexity and laborious nature makes it difficult to be administered in
large sample populations. Therefore, due to its practicality, the minimal model Oral
Glucose Tolerance Test (OGTT) is commonly used in the clinical setting to assess
insulin sensitivity. These two methodologies have demonstrated to be effective in
detecting differences in insulin sensitivity across various age groups and races (Table
2). (Appendix B). Table 2. depicts the relevant studies which employed various
techniques to quantify insulin sensitivity.
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Table 2. Literature Overview- Effects of family history of type 2 diabetes on insulin
sensitivity – sorted for Insulin Sensitivity Methodology
Author

Status

Method

Outcome
FH+ vs.
FHArslanian et Normoglycemic Hyperinsulinemic ¯ IS in FH+
al. 2005
euglycemic clamp

Age

Sex

Race

11-12

25M/29F

White

Petersen et Insulin resistant Hyperinsulinemic ¯ IS in FH+
al. 2004
&
euglycemic clamp
Insulin sensitive

19-36

8M/18F

Black
White

Perseghin Normoglycemic Hyperinsulinemic ¯ IS in FH+
et al. 1997
euglycemic clamp

19-41

28M/50F

Mexican

Groop et al. Normoglycemic
OGTT
¯Glucose
1996
Hyperinsulinemic tolerance in
euglycemic clamp
FH+
¯ IS in FH+
Gulli et al. Normoglycemic
OGTT
No
1992
Hyperinsulinemic Difference
euglycemic clamp in OGTT
¯ IS in FH+
Van
Normoglycemic
OGTT &
No
Haeften et
Hyperglycemic
Difference
al. 1998
clamp

35-65

46M/39F

Hispanic

34-42

3M/18F

MexicanAmerican

44-47

8M/34F

White

¯Glucose
tolerance in
FH+
¯Glucose
tolerance in
FH+

31-65

183M/240F

Chinese

26-52

52M/36F

White

Wang et al. Normoglycemic
2008

2-h OGTT

Ishikawa et Normoglycemic
al. 1998

2-h OGTT

Haffner et
al. 1997

Normoglycemic

2-h OGTT

¯Glucose
tolerance in
FH+

25-65

533M/743F

Osei et al. Normoglycemic
1991
Ryder et al. Normoglycemic
2003

2-h OGTT
FSIVGTT
HOMA-IR

¯ IS in FH+

24-30

4M/16F

Hispanics
&
African
Americans
N/A

¯ IS in FH+

18-68

66M/77F

Hispanic

Guerrero et Normoglycemic
al. 2005

HOMA-IR

¯ IS in FH+

18-24

18M/30F

White

QUICKI

¯ IS in FH+

18-65

602 M&F

White

PerezFuentes et
al. 2014

Normoglycemic

2-h OGTT: 2-hour Oral Glucose Tolerance Test; FSIVGTT: Frequently Sampled Intra-venous Glucose Tolerance
Test; HOMA-IR: Homeostatic Model Assessment of Insulin Resistance; QUICKI: Quantitative Insulin Sensitivity
Check Index.

Furthermore, Gulli et al., (1992), demonstrated that during a hyperglycemic
clamp, the amount of glucose metabolized per unit of plasma insulin concentration was
4

37% lower in subjects with FH+ versus FH-. It was also demonstrated that at steadystate during a hyperglycemic clamp, plasma insulin levels of FH+ subjects were
significantly elevated compared to the FH-, supporting the notion of decreased insulin
sensitivity in FH+ subjects. This study showed that participants with FH- require a higher
glucose infusion rate compared to FH+ individuals to achieve the same plasma glucose
values [15].

Metabolic Flexibility
In addition to impaired insulin sensitivity, it has been demonstrated that FH+ also
have a diminished metabolic flexibility [7, 15-19]. Metabolic flexibility is defined as the
ability to switch from fat to carbohydrate oxidation in response to a meal or insulin
administration [20]. It has been shown that metabolically flexible individuals
predominantly oxidize fat as the main source of fuel during fasting condition and are
promptly able to switch to carbohydrate oxidation in response to insulin [15]. On the
other hand, metabolically inflexible individuals exhibit a lower rate of fat oxidation at rest
and lack the capability of switching to carbohydrate oxidation after insulin administration
[16, 18, 19, 21-25].
Moreover, as demonstrated by Gulli et al., (1995), FH+ participants relied less on
fat oxidation during resting conditions compared to FH- and were not able to switch to
carbohydrate oxidation to the same extent as FH- during a hyperinsulinemic-euglycemic
clamp. Additionally, in regard to metabolic flexibility, Ukropcova et al., (2007) showed
that FH- and FH+ individuals displayed similar metabolic flexibility during a
hyperinsulinemic-euglycemic clamp. On the contrary, Groop et al., (1996) demonstrated
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that FH- and FH+ subjects displayed virtually the same rates of lipid and glucose
oxidation during fasted and insulin stimulated conditions. The inability to suppress lipid
oxidation during insulin stimulated conditions with FH+ is an indicator of compromised
metabolic flexibility [15]. Metabolic flexibility has been shown to be compromised in
obese individuals by a markedly lower capacity for fat oxidation during fasted conditions
[21]. In a previous study, it was reported that obese individuals have a higher 24-hour
respiratory quotient (RQ), which is indicative of low fat oxidation during resting
conditions. Individuals with T2D were also reported to show signs of compromised
metabolic flexibility during the hyperinsulinemic-euglycemic clamp. When compared to a
control group (FH-), individuals with T2D were not able to increase glucose uptake
during insulin-stimulated conditions [18]. Sparks et al., (2009), suggested that metabolic
inflexibility is a fundamental early component of the “dysmetabolic” syndrome and
provides new insight into why some people develop diabetes and some do not. This
suggests that early interventions are essential to reverse these defects to help prevent
T2D and cardiovascular diseases [16].

Myokine Secretion
Myokines, which are cytokines secreted from the skeletal muscle [26], have been
shown to be influenced by the contractile activity of muscle, thus linking physical activity
to myokine secretory response [27]. Skeletal muscle is the largest organ in individuals
with a healthy body weight and activity level and accounts for ~40% of body weight [28].
Given that skeletal muscle is now recognized as an endocrine organ, it is important to
investigate the effects that are elicited by muscular contraction. Recent research has
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shed light on the pro/anti-inflammatory properties of several novel myokines [29].
Myokine secretion, or low-grade systemic inflammation, has been linked to insulin
sensitivity, inflammation, metabolic function, obesity and T2D [28, 30-32]. The antiinflammatory effects of exercise have shown not only to reduce inflammation but also to
improve insulin resistance. As demonstrated by King et al., (2002) a strong inverse
association between systemic low-grade inflammation and level of physical activity was
observed. Numerous myokines have been associated with insulin resistance, obesity,
and T2D, including interleukin 6 (IL-6) [33], interleukin 15 (IL-15) [34], myostatin [35],
tumor necrosis factor-alpha (TNF-a) [36], and leukemia inhibitory factor (LIF) [37].

Exercise Induced Improvements in Insulin Sensitivity and Metabolic Flexibility:
It is well established that exercise training improves insulin sensitivity. Short term
exercise training studies (2 – 6 weeks) reported a significant improvement in fasting
plasma glucose [38], fasting insulin [38, 39], glucose tolerance [40], and insulin
sensitivity measured by the gold standard, hyperinsulinemic-euglycemic clamp [41].
These improvements have been reported in healthy sedentary individuals [42], obese
individuals [43, 44], as well as individuals with T2D [38]. Similarly, long-term exercise
training studies have also reported significant improvements in fasting plasma glucose
[45-47], fasting insulin [48-50], glucose tolerance [45, 51], and insulin sensitivity [48, 49].
These improvements following exercise training have been reported in various
populations including healthy sedentary, obese [47, 52], and population with T2D [45,
46, 51]. Moreover, lifestyle exercise interventions (1 & 2 years) that include exercise
and exercise plus a controlled diet group (reducing saturated fat to 10% of energy and

7

increasing monounsaturated fat to 10-15% of energy intake with macronutrient
proportions of ~16% protein, ~37% fat, ~47% carbohydrate) have been performed on
FH+ individuals by Brekke et al., (2005) and Wing et al., (1998) [44, 50]. Both studies
reported that following the 2-year intervention, the diet, exercise, and diet + exercise
groups significantly improved their fasting plasma insulin compared to control groups
which did not take part in exercise or diet interventions. A greater degree of
improvement was evident in the diet + exercise group compared to the control group.
Currently, a coherent body of literature examining exercise induced improvements in
healthy, sedentary individuals, particularly for those with a family history of T2D, is not
complete. Additional research that investigates the effects of exercise on insulin
sensitivity, fasting glucose, and fasting insulin in healthy sedentary individuals is
needed.

Training Mode
The type of exercise, whether it is aerobic, [38, 39, 43, 44, 48-50, 53, 54],
resistance [38, 55, 56], or combined [38, 45-47, 51, 52, 57] have shown to be beneficial
and contribute towards the prevention of T2D. Aerobic exercise interventions have
demonstrated to be effective in improving insulin sensitivity [38, 41, 43, 44, 49, 54],
metabolic flexibility [53], and myokine secretion [44, 46, 49, 54], in sedentary [41, 49,
53], obese [43, 54], and T2D subjects [18, 38, 54]. Additionally, resistance exercise
training interventions have also been shown to effectively improve insulin sensitivity [18,
55, 58-63], metabolic flexibility [18], and myokine secretion [46]. These improvements
were evident in sedentary [62], obese [58, 61], and T2D subjects [46, 55, 59, 60, 63].
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Furthermore, combined exercise training interventions or the concurrent training of
aerobic and resistance exercise, have shown to be an effective tool to improve insulin
sensitivity [18, 38, 45, 51, 52, 64], enhance metabolic flexibility [18, 52], and improve
myokine expression [46] in sedentary [64], obese [47, 52], and T2D subjects [18, 38, 45,
46, 51]. Exercise training, whether it be aerobic, resistance, or combined has been
shown to be a potent tool to delay or prevent the onset of T2D by improving insulin
sensitivity, metabolic flexibility, and myokine expression. Although it is well established
that aerobic, resistance and combined exercise training improve insulin sensitivity,
metabolic flexibility and myokine expression, the body of literature concerning of these
effects on FH+ individuals is limited. Additionally, it remains unclear whether FH+ is
detrimental to Mexican-Americans and if their family history of T2D is restrictive of
exercise induced improvements.

Exercise Mediated Improvements in Myokine Secretion
Current research has aimed at identifying the relationship between the pancreas
and skeletal muscle in response to exercise. Recent data suggests that chronic
inflammation is involved in the pathogenesis of pancreatic cell death, atherosclerosis,
and insulin resistance and most profoundly in T2D and cardiovascular disease [65].
According to Pedersen et al., (2017), inflammation accompanied by elevated circulating
levels of cytokines are found in individuals with insulin resistance and T2D. As
demonstrated by Pedersen et al., (2003), the endocrine effects of skeletal muscle
derived peptides produced and secreted during skeletal muscle contraction known as
myokines [66], have been shown to have beneficial effects on glucose uptake [34, 67],
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glucose tolerance [68], and regulation of fat oxidation [65, 68]. Additionally, it has been
demonstrated that IL-6, a myokine that promotes glucagon-like peptide-1 (GLP-1)
secretion and production in intestinal L cells and pancreatic b-cells contribute to the
improvement of glycemic control [69]. These increases of IL-6 and GLP-1 led to
improved glucose tolerance and b-cell insulin secretion [69]. This could provide an
explanation to the increase of GLP-1 levels in the blood during exercise, which may be
due to skeletal muscle derived IL-6 [69]. IL-6, extensively reviewed by Pedersen et al.,
(2016), has been speculated to contribute to both the pro-inflammatory and antiinflammatory effects of exercise, regulate glycogen content in skeletal muscle, and
contribute to insulin sensitivity through AMP-kinase (AMPK) activation [70]. IL-6 is
produced in larger amounts compared to other myokines [71]. Wallenuius et al., (2002),
conducted a study using IL-6 knockout mice that demonstrated to be insulin resistant
and obese. Following 18 days of IL-6 administration, body weight and abdominal fat
were significantly decreased in the same IL-6 knockout mice [72].
Numerous studies have shown that myokine secretion is induced by exercise. It
has been shown that circulating IL-6 can increase up to 100-fold depending on the
duration of exercise and the amount of muscle engaged in exercise [66]. This increase
in IL-6 has been associated with increased glucose uptake, fatty acid oxidation, and
enhanced insulin secretion which further contributes to increased glucose uptake into
skeletal muscle [73]. Skeletal muscle’s ability to adapt to exercise by enhancing boxidation of fatty acids, glycogen content, and intramyocellular triglyceride hydrolysis
allows trained athletes to use lipid as a substrate and rely less on glucose and muscle
glycogen during exercise [74].
10

In addition to IL-6, another myokine of interest, interleukin-15 (IL-15), has been
interconnected to body weight and insulin sensitivity which has been demonstrated to
regulate metabolic diseases such as obesity and diabetes [68]. It has been
demonstrated that IL-15 increases glucose transporter 4 (GLUT4) expression which, in
turn, increases glucose uptake into skeletal muscle cells [29]. Moreover, incubation of
muscle in IL-15 has been shown to promote GLUT4 mRNA, suggesting an increase in
glucose uptake capabilities [34]. Additionally, it has been demonstrated that 30-minutes
of treadmill running at 70% of age predicted maximal heart rate significantly increased
circulating levels of IL-15 in healthy untrained young men [75]. A study conducted by
Riechman et al., (1996), demonstrated that after 10-weeks of moderate-intensity
resistance exercise training, IL-15 was significantly elevated compared to pre-exercise
level. These findings remained the same following the 1st session (acute effect) to
following the 30th session in week 10 of the intervention (chronic effect) [76].
Furthermore, the role of IL-15 in lipid metabolism has been investigated in transgenic
mice (TG) that possess elevated levels of circulating IL-15 and have shown to have
higher insulin sensitivity and increased expression of various markers associated with
lipid metabolism [67]. Quinn, et al. (2013), conducted a similar study that also used TG
mice with elevated levels of IL-15 and demonstrated that TG mice had a significantly
greater lipid oxidation capacity compared to control mice at rest and during a run to
exhaustion test [77]. Given that IL-15 holds a pivotal role in glucose and lipid
metabolism, it may serve an important role in regulating metabolic diseases such as
T2D and obesity [78].
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Myostatin, another myokine that is downregulated during exercise has been
associated with muscle growth regulation [79]. It has been shown that following 5 days
of resistance training, myostatin levels decreased 44%, 24 hours after the last bout of
exercise [80]. Given that myostatin has been shown to hinder hypertrophy, the
downregulation of myostatin after resistance exercise is supported by increases in
muscle mass [80]. A 6-month aerobic exercise training (40 – 55% peak VO2) study
conducted by Hittel et al., (2010), demonstrated that plasma myostatin concentrations
post-intervention significantly decreased and strongly correlated with improvements in
Insulin sensitivity [35]. Furthermore, short-term endurance training has been
demonstrated to elicit a downregulation of myostain in rats; with as little as 5 days of
swimming for 60-minutes per day, myostatin levels decreased in the gastrocnemius and
vastus lateralis [81].
These skeletal muscle specific proteins and the effects of exercise training on
myokine secretion in Mexican-American FH+ vs. FH- individuals is unclear. Establishing
a clear link between myokines and their contribution to insulin sensitivity, metabolic
flexibility, and inflammation will be essential to further understand potential mechanisms
involved in the development of T2D. Additionally, understanding these mechanisms can
lead to the identification of potential targets that can help prevent T2D through exercise
prescription or through pharmacological agents.

Purpose & Specific Aims
Current research concerning contributing factors to the pathogenesis of T2D has
established that certain factors such as family history of T2D, ethnicity, chronically
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elevated levels of inflammation markers, body fat, and lack of exercise can all increase
an individual’s susceptibility to develop the disease. However, it still remains unclear
whether a family history of T2D in Mexican-Americans impacts exercise mediated
improvements in insulin sensitivity, metabolic flexibility, and myokine concentrations.
Therefore, the primary purpose of this study was to evaluate the effects of 8 weeks of a
combined exercise training intervention on insulin sensitivity, metabolic flexibility, or
myokine secretion in Mexican-American males with and without a family history of T2D.
Specific aims:
1.

To determine if normoglycemic, otherwise healthy, Mexican-American males with
a first-degree family history of T2D are more insulin resistant and metabolically
inflexible compared to age and BMI, matched individuals without a family history
of T2D.

2.

To determine whether normoglycemic, otherwise healthy, Mexican-American
males with a first-degree family history of T2D are able to achieve exerciseinduced improvement in insulin sensitivity and metabolic flexibility to a similar
extent after 8 weeks of combined endurance and resistance exercise training
compared to those without a family history of T2D.

3.

Exploratory aim: To determine whether normoglycemic, otherwise healthy,
Mexican-American males with a first-degree family history of T2D have
alterations in plasma profile of key myokines and cytokines at baseline, after
acute bouts of aerobic and resistance exercise, and after the 8-weeks of
combined exercise training.
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The border region of El Paso population consists of 87% Hispanics, who have a
greater risk for developing T2D compared to non-Hispanic whites. Statistically, 9.4% of
Americans have been diagnosed with T2D (CDC, 2017), compared to approximately
13.8% Hispanic adults in the US (diabetes.org, 2018). Furthermore, over the course of
their lifetime, over 50% of Hispanic men and women, are expected to develop T2D
(CDC.gov, 2018). Locally, about one in eight adults in El Paso have been reported to
have T2D (healthypasodelnorte.org, 2017). The proposed study is not only relevant to
the border region of El Paso which has a high Mexican-American population of 82.2%
(Census.gov, 2010), but will also help answer important questions regarding exercise
induced prevention of T2D and molecular mechanisms involved in an at-risk MexicanAmerican population.
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Chapter 2: Methods
Twenty-two normoglycemic, healthy sedentary Mexican-American males
between the age of 18 and 40 years were recruited to this study and were assigned into
one of two groups based on whether none of the parents (FH-, n=10) or one/both
parent(s) is/are diagnosed with T2D (FH+, n=12). Self-reported non-diabetic parental
status in the FH- group was confirmed in 4 of the 9 participants. Two participants from

Study Design

the FH+ group dropped out of the study and were excluded from the statistical analyses.
A subject from FH- group was excluded from statistical analyses due to noncompliance

Study Design

to the exercise training sessions; Thus, providing a final group allocation of FH-, n=9
and FH+, n=10. The study protocol was approved by the University of Texas at El Paso
(UTEP) institutional review board.
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Screening Visits

Once subjects were recruited, an over the phone questionnaire was administered
to determine eligibility (Appendix C). When the subject’s eligibility and MexicanAmerican status through self-report was confirmed, a meeting was scheduled to obtain
informed consent. After informed consent was obtained it was determined if subjects
met any of the exclusion criterion (Table 4). If none of the exclusion criteria were met,
subjects were issued an accelerometer (Table 3. S1-S7). The purpose of the
accelerometer was to assess physical activity level of the participants. Less than 60
minutes spent in moderate to vigorous physical activity per week was considered
sedentary [82]. If the participant met the sedentary physical activity criteria, the
participant was then instructed to return for a maximal aerobic capacity (VO2max)
assessment (Table 3. B3), upper and lower body 1 repetition maximum (1RM) muscular
strength (Appendix D) (Table 3. B2), body composition (Table 3. B5), and family history
of disease questionnaire (Appendix E). Five days before the baseline measurement of
insulin sensitivity by the gold standard hyperinsulinemic euglycemic clamp, all subjects
reported any food allergies (Appendix F) and were provided with a standard diet (55%
carbohydrate, 15% protein, 30% fat) (Table 3. B1-B5) to control for dietary effects on
insulin sensitivity. Participants were asked to arrive at the UTEP Health Sciences
building the day of the clamp after an overnight fast for assessment of insulin sensitivity
and metabolic flexibility using the hyperinsulinemic euglycemic clamp (Table 3. B6).
Indirect calorimetry was used to assess resting metabolic rate and metabolic flexibility
before and after insulin stimulated conditions during the clamp. Fasting blood samples
were collected to determine complete metabolic panel, thyroid function, lipid profile,
insulin, and myokine concentrations (Table 3. B6).
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Table 3. Schedule
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Subjects were instructed to report the Monday after the baseline
hyperinsulinemic euglycemic clamp for the first day of training. Exercise training was
composed of 3 combined exercise training sessions (aerobic & resistance) per week
that lasted for approximately 75 minutes per session for a total of eight weeks. During
the first week of training, blood was drawn during fasted conditions before and
immediately after the first aerobic exercise bout (Table 3. day 1 of week 1) and first
resistance exercise bout (Table 3. training day 2 of week 1) to assess myokine
secretion after one acute bout of aerobic and resistance training. Similarly, blood was
also drawn before and immediately after the last bout of aerobic (Table 3. day 1 of week
8) and resistance (Table 3. day 3 of week 8) exercise during the last week of exercise
training to assess the effects of 8 weeks of combined exercise training on acute
myokine response to exercise training. One repetition maximum was assessed at
baseline (day 2), Mid-intervention (week 5, D1) and post-intervention (week7, D2 (Table
1). Subjects were provided with a standard diet, five days before the post intervention
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clamp. Similar to baseline testing, insulin sensitivity, metabolic flexibility, body
composition, complete metabolic panel, thyroid function, lipids, insulin, and myokine
concentration were re-assessed during the post-intervention clamp protocol. A detailed
description of these tests are provided below.
Table 4. Inclusion/Exclusion Criteria
Inclusion Criteria
1. 18 ≤ Age ≤ 40 years
2. 18 ≤ BMI ≤ 30 kg/m2
3. Both parents are Mexican/
Mexican-American
4. Sedentary lifestyle
Less than 60 minutes/wk. of
moderate to vigorous
intensity
physical activity (MVPA)

Exclusion Criteria
1. Evidence of significant cardiovascular disease
or diabetes
2. A fasting blood glucose ³ 100 mg/dl
3. Screening blood pressure ³ 140/90
4. Hyperlipidemia- Total cholesterol ≥ 240mg/dl
5. Use of drugs affecting energy metabolism or
body weight
6. Excess alcohol, drug abuse, and smoking
7. Eating disorder or eating attitudes interfering
with study
8. Unwillingness to be abide by randomization

Table 5. Screening measurements
Measurement

Method

Sedentary physical activity level Physical activity questionnaire & time spent in
moderate to vigorous physical activity (MVPA)
<60 minutes per week.
Fasting Blood Glucose
Blood sample via lancet stick/analysis via true
result blood glucose meter
Lipid Profile (screening) (HDL, Blood sample via lancet stick/analysis through
LDL, Total Cholesterol)
point of care testing (Alere, Cholestech LDX)
Blood Pressure
Automated blood pressure device
Body Mass Index (BMI)
Height & weight measurements
Medical History
Questionnaire
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Table 6. Study variables
Variable
Body Composition

Method of Measuring
Air displacement plethysmography (BodPod) & dual
energy X-ray absorptiometry (DXA)
Maximal Aerobic Capacity Standard graded exercise
Insulin Sensitivity
Hyperinsulinemic-euglycemic clamp
Glucose tolerance
Oral glucose tolerance test (OGTT)
Metabolic Flexibility
Indirect calorimetry- change in respiratory quotient (delta
RQ) from fasting to insulin stimulated condition
Resting Metabolic Rate
Indirect calorimetry
Plasma Lipids (HDL, LDL, Laboratory Corporation of America ©
Cholesterol, Triglycerides)
Myokine & Cytokine
Concentration
Fasting Insulin and
Glucose Concentration

MYOMAG-56K | MILLIPLEX MAP Human Myokine
Magnetic Bead Panel
Laboratory Corporation of America ©

Anthropometric Measurements
Height (cm) and weight (kg) measurements were taken to determine body mass
index (BMI, kg/m2) before and after the 8 weeks of combined exercise training. Waist-tohip ratio (WHR, Waist-cm/Hip-cm) was calculated by measuring the narrowest part of
the waist, right above the navel and dividing this value by the circumference of the hips
or at the greater trochanter (Appendix G).

Physical Activity Measurement
Sedentariness of the participants was confirmed via questionnaire (Appendix H)
as well as sedentary level of physical activity was determined by calculating the time
spent in moderate to vigorous physical activity (<60 minutes per week) [82] (Appendix
I). ActiGraph activity Monitor (GT3XP-BTLE 2GB) was clipped to the belt or pants of the
subjects closest to the anterior superior iliac crest and was worn for 7 days (Monday19

Sunday) including sleep time. After the 7-day wear time (>90% wear time), the subject
reported to the research facility and participant’s physical activity was quantified.

Dietary Control
Breakfast, lunch, dinner, and snacks were measured, weighed and prepared by
day and separated by meal into their daily containers (Appendix J). Subjects were
maintained on the diet for the five days prior to the baseline and five days before the
end of the intervention to minimize the effects of diet on insulin sensitivity and plasma
markers. Meals were designed to comply with the USDA 2010 Dietary Guidelines for
Americans and individualized to participant preferences. This consisted of ~55% energy
from carbohydrate, ~15% energy from protein and ~30% energy from fat (with no more
than 10% from saturated fat). The Mifflin St Jour equation was utilized to match the
participants estimated energy requirements with the diet provided. During the exercise
training, participants were encouraged to follow the USDA 2010 Dietary Guidelines for
Americans (as detailed above) and to consume an energy balanced diet.

Air Displacement Plethysmography (BodPod):
Participants were asked to sit in an air displacement plethysmography chamber
(BodPod) (Life Measurement, INC. Concord, CA) for about 45 seconds, maintain the
sitting position, and breathing as normally as possible. Compression/tight fitting clothing
such as tights and spandex, along with a swimming cap were required. The subject’s
body mass, body volume, or amount of air displaced were determined to calculate the
percentage of fat and fat free mass.
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Dual Energy X-ray absorptiometry (DXA)
Subjects were asked to lie supine on the scanner table of a GE Dual Energy Xray Absorptiometry (GE Medical Systems. Madison, WI) system. Arms were kept close
to the body while knees and ankles were lightly strapped to prevent movement in the
lower extremities [83]. The scanner bar traveled from head to toe. The time spent for
the measurement was about 15 to 20 minutes, depending on the body the size of the
subjects. Lean mass, fat mass, bone mineral density (BMD), and bone mineral content
(BMC) measurements were obtained.

Maximal Aerobic Capacity
Maximal aerobic capacity (VO2max) was measured using a standardized graded
treadmill laboratory protocol. Subjects began the test on a treadmill at 3 mph and a 3%
incline for the first 3 minutes to determine the oxygen consumption at an absolute
workload, it was followed by a 2-minutes warm up at 5 mph at 0% incline. The
remainder of the test was performed at a comfortable speed (5-6 mph) chosen by the
participant while increasing 1% incline every minute. Subjects’ rate of perceived
exertion (RPE) and heart rate (HR) were monitored throughout the test. Once the
subject reached volitional exhaustion the test was terminated. Standard measurements
of VO2 and VCO2 were used to determine respiratory exchange ratio (RER) throughout
the exercise test using a Parvomedics TrueOne 2400 metabolic measurement cart (Salt
Lake City, UT). Maximal aerobic capacity was determined once the subject has met 2
out of the 4 following criteria: 1) respiratory exchange ratio (RER) >1.1, 2) ±10 beats per
minute from age predicted maximal heart rate, 3) RPE >17 as demonstrated by
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Evardesen et al., 2014, 4) plateau in oxygen consumption with increased intensity for 1
minute [84]. (Appendix K).

One Repetition Maximum
One repetition maximum strength (1-RM) was performed before the first week
and on the last week of the exercise training period. Upper body strength was assessed
though a 1-RM bench press and lower body strength was assessed through a 1-RM
back leg strength dynamometer. Mid-term 1-RM testing was administered on the first
day of training of the fifth week.

Hyperinsulinemic-euglycemic Clamp
The hyperinsulinemic euglycemic clamp is considered the gold-standard
measurement for insulin sensitivity [85]. Participants were asked to arrive at the UTEP
Health Sciences building following an overnight (12-h) fast. A catheter was inserted into
a forearm vein for infusion of insulin and glucose; another catheter was inserted into a
contralateral dorsal hand vein warmed in a heating blanket for arterialized-venous blood
sampling. Prior to insulin and glucose infusion, fasting insulin and blood glucose
samples (6 ml for each) were obtained. A primed continuous infusion of regular insulin
(2.5 ml) (Humulin, Eli Lilly and Co., Indianapolis, IN) was added to a 250 ml saline bag
and was administered at an initial rate of 313 mU/min/m2. This large bolus of insulin was
used in order to suppress b-cell insulin secretion. The initial insulin loading dose of 80
mU/min/m2 was calculated by multiplying the body surface area (BSA) by the desired
insulin dose (80 mU/min) then dividing this product by 1000 to account for the milliliters

22

and multiplying the remainder by 60 (minutes in an hour), this yields the insulin infusion
rate (mL/h). Insulin was infused along with a 20% dextrose solution to maintain blood
glucose at a concentration of 90 mg/dl throughout the clamp period. A 0.5 mL blood
sample from the forearm vein was drawn every 5 minutes throughout the duration of the
clamp. A waste sample of 1.5 times the dead space of the micro-bore extension set
(approximately 1 mL) was pulled prior to each collection of the 0.5 mL blood sample.
The samples were analyzed immediately for glucose concentrations (YSI 2300 STAT
Plus Glucose/Lactate Analyzer). Insulin concentration were measured from blood drawn
pre- and post-clamp. Insulin sensitivity was determined from the glucose disposal rate
(mg/kg estimated metabolic size (EMBS)/min) on the last 15 minutes of the clamp [86].
Following cessation of insulin administration, the final glucose infusion rate (ml/hr) was
increased by 30% for 10 mins to prevent hypoglycemia. If euglycemia was maintained,
the glucose infusion rate was decreased to 10% of the final glucose infusion rate for 10
minutes. At the end of this 15-minute period, if euglycemia was maintained (i.e. 3
consecutive concentrations within 10mg/dl), there was cessation of glucose infusion.
The participant continued to be monitored for 30 minutes. Blood samples were collected
at 10-minute intervals. Following the 2-hour procedure, the participant was given a
snack and beverage and allowed to leave the laboratory after consuming the meal.
Resting Metabolic Rate

Resting metabolic rate (RMR) was measured via indirect calorimetry using a
Parvomedics TrueOne 2400 metabolic measurement cart (Salt Lake City, UT). On the
same day as the clamp, participants’ RMR and respiratory quotient (RQ) were
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determined by indirect calorimetry. Participants were placed into a semi-recumbent
position and a hood was placed over their head for measurement of oxygen utilized and
carbon dioxide produced. Participants were instructed to breathe normally during this
30-min collection period. This procedure was completed in fasting conditions and again
during the last 30-min of the clamp (insulin stimulated conditions) for the determination
of metabolic flexibility.

Metabolic Flexibility
The respiratory quotient (RQ) values were acquired through indirect calorimetry
using the hood and canopy method in order to determine the volume of CO2 expired and
volume of O2 inspired to calculate metabolic flexibility, as described before [86]. Delta
RQ was derived by subtracting the fasting RQ from the insulin stimulated RQ during the
clamp. This determined to what degree subjects were able to shift from fat to
carbohydrate oxidation during an insulin stimulated condition.

Oral Glucose Tolerance Test (OGTT)
Participants were asked to arrive at the UTEP Health Sciences building and to
avoid eating, drinking, smoking or strenuous exercise for 10-12 hours prior to testing.
Participants were asked to remain seated while a fasting blood sample was collected
via finger stick. The participant then orally ingested 75 grams of glucose as quickly as
possible. Blood samples were collected at timed intervals of 15, 30, 60, 90, 120, 150,
and 180 minutes following ingestion of the glucose. Blood glucose was analyzed via
true result handheld blood glucose meter. Glucose tolerance was assessed by
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calculating the area under the curve determined from blood glucose concentrations
during the 3 hours of the test (Appendix L). The area under the curve was calculated by
using the trapezoidal rule in which the integral was defined, then divided into segments
and deriving the sum of the segments.

Fasting glucose and Fasting insulin
On the same day of the clamp, an intravenous blood sample was obtained from
the IV line for analysis of fasting insulin and fasting glucose. Fasting blood glucose was
analyzed via the YSI 2300 STAT PLUS glucose and L-Lactate analyzer. Fasting blood
insulin was analyzed by Laboratory Corporation of America (Burlington, NC.).

Lipid Profile
On the same day of the clamp, an intravenous blood sample was obtained from
the IV line for analysis of low-density lipoproteins (LDL), high-density lipoproteins (HDL),
triglycerides (TG) and total cholesterol. Blood samples were evaluated by Laboratory
Corporation of America (Burlington, NC.).
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Myokine and Cytokine Concentration
On the same days of the clamp, an intravenous blood sample was obtained from
the IV line for analysis of myokine concentrations at baseline and at the end of the
exercise intervention. Additionally, intravenous blood samples were obtained before and
immediately after a bout of aerobic and resistance exercise at the beginning and at the
end of the 8-week exercise training intervention (Table 3) to evaluate the effects of 8
weeks of combined exercise training on acute exercise response of myokines. Blood
samples were collected and centrifuged to isolate serum and were stored at -80 °C.
Serum for each time point were pooled for myokine analyses for FH- and FH+ groups.
Serum IL-15, IL-6 and, Myostatin concentrations were measured using a magnetic
bead-based multiplex assay (milliplex® MAP Human Myokine Magnetic Bead Panel.,
R&D systems, Minneapolis, MN, USA).

Exercise Intervention
All participants exercised at the UTEP Research Fitness Facility located within
the Ross Moore building. All exercise sessions were supervised by trained graduate
students to ensure safety and compliance to exercise prescriptions. Exercise training
consisted of 8 weeks of combined aerobic and resistance training performed 3 days of
the week (30 min aerobic and 30 min resistance per training day). For the aerobic
training, subjects began training at 55% of their maximum aerobic capacity (VO2max),
increasing 5% every two weeks up to 70% of VO2max. For the resistance training,
subjects performed 3 upper-body and 3 lower-body resistance exercise with intensity
set at 3 sets of 8 repetitions. Exercises were rotated from a pool of 20 exercises (Lower
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body exercises: barbell squat, dumbbell squat, dumbbell goblet squats, dumbbell sumo
squats, dumbbell lunges, barbell deadlift, dumbbell deadlift, weighted glute bridges;
Upper body exercises: flat barbell bench press, incline barbell bench press, flat
dumbbell bench press, incline dumbbell bench press, Latissimus pull down, cable row,
dumbbell row, barbell row, dumbbell shoulder press, dumbbell lateral raises, dumbbell
front raises, triceps extensions). Measurements of strength were performed before the
first week (baseline), on the first day of training of the fifth week (mid-intervention), and
on the last week (post-intervention) of the exercise training period (1RM bench press &
back leg strength dynamometer) (Appendix E).

Statistical Analysis
Statistical analyses were performed using GraphPad Prism, version 6.0
(GraphPad Software Inc, La Jolla, California). Two-way ANOVA with repeated
measures was used to compare groups (FH-, FH+), time (before vs. after intervention)
and group by time effects. Results are reported as mean ± SEM, significant differences
were to be assumed for p<0.05.
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Chapter 3: Results
Table 7. Summarizes the outcome measures of study participants (FH- (n=9) and FH+
(n=10)) who completed the 8-week combined exercise training intervention. Compliance
rate was set at 100%. Three participants were excluded from the analyses due to noncompliance to the exercise training sessions. Age (FH- 21.89 ± 0.60 yrs, FH+ 23.41 ±
0.86 yrs; p=0.25), BMI (FH- 27.51 ± 1.68 Kg/m2, FH+ 26.64 ± 1.02 Kg/m2; p=0.65), fat
free mass (FH- 54.82 ± 2.28 kg FH+ 51.14 ± 1.58 kg; p=0.19), and fat mass (FH- 23.44
± 3.03 kg, FH+ 24.23 ± 1.97 kg; p=0.82) were not significantly different between groups
at baseline. Insulin sensitivity between groups was not significantly different at baseline
(FH- 2.99 ± 0.27; FH+ 3.63 ± 0.50 ml/kg estimated metabolic body size (EMBS), p=0.3).
Metabolic flexibility between groups was not significantly different at basline (FH- 0.07 ±
0.01; FH+ 0.08 ± 0.01, p=0.72). Insulin sensitivity significantly improved in both groups
(FH- 2.99 ± 0.27 to 3.89 ± 0.28 ml/kg (EMBS), p=0.02; FH+ 3.63 ± 0.50 to 4.82 ± 0.51
ml/kg EMBS; p=0.002). Improvement in insulin sensitivity expressed as percent (%)
change were not significantly different between groups (FH- 34.90 ± 11.00 % vs. FH+
40.66 ± 12.19 %; p>0.05). Metabolic flexibility did not improve in either FH- or FH+
groups (FH- 0.07 ± 0.01to 0.09 ± 0.01, p=0.71; FH+ 0.08 ± 0.01 to 0.11 ± 0.02, p=0.24).
Regardless of normal glucose tolerance (blood glucose <140 mg/dl, 2 hours post
glucose ingestion during OGTT), the FH+ group displayed a significantly higher blood
glucose area under the curve 2 hours post glucose load after the baseline OGTT test
(FH- 217.91 ± 5.39 AUC vs. FH+ 264.38 ± 12.67 AUC, p=0.004) as well as 3-h after
glucose ingestion (FH- 307.09 ± 6.14 vs FH+ 354.12 ± 13.5, p=0.007). The FH+ group
significantly decreased glucose AUC during the 2h-OGTT (264.38 ± 12.67 to 237.54 ±
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11.77 AUC, p=0.002) after 8-weeks of combined exercise training. Fasting insulin
significantly decreased (12.9 ± 2.45 to 10.12 ± 1.59 mIU/L, p=0.02) in the FH- group.
HOMA-IR was not significantly different at baline between groups (FH- 2.51 ± 0.51 %
vs. FH+ 1.92 ± 0.19 %; p>0.97). HOMA-IR significantly improved in the FH- group (2.51
±0.51 to 1.97 ± 0.32 AU, p=0.03). Improvement in body weight expressed as percent
change was significantly different between groups with the FH- group having a
significant higher increase (FH- 3.42 ± 0.80 % vs. FH+ 0.95 ± 0.68 %; p=0.03). Percent
body fat significantly decreased in the FH+ group (FH+ 31.63 ± 2.06 to 30.01 ± 1.9 kg,
p=0.005). Fat free mass significantly increased in both groups (FH- 54.82 ± 2.28 to
56.52 ± 1.87 kg, p=0.02, FH+ 51.14 ± 1.58 to 53.42 ± 1.8 kg, p=0.001. Aerobic fitness
significantly increased in the FH+ group (3.57 ± 0.16 to 3.82 ± 0.16 L/min p=0.001;
44.48 ± 1.82 to 47.18 ± 2.00 ml/kg/min p=0.01) ) while the FH- group did not increase
aerobic fitness (3.84 ± 0.23 to 3.97 ± 0.21 L/min p=0.11; 46.25 ± 1.55 to 47.51 ± 0.98
ml/kg/min p=0.33) Upper body strength (FH- 155.00 ± 20.83 to 181.10±21.13 lb,
p=0.0001; FH+ 148.50 ± 16.87 to 178.00 ± 16.75 lb, p=0.0001) and lower body strength
(FH- 354.44 ± 31.97 to 416.67 ± 27.55 lb, p=0.0006; FH+ 356.00 ± 20.18 to 419.50 ±
15.99 lb, p=0.0003) significantly increased in both groups. High density lipoproteins
(HDL) significantly increased (31.44 ± 2.21 to 35.00 ± 2.36 mg/dl, p=0.03) in the FHgroup. Total cholesterol to HDL ratio significantly improved (4.57 ± 0.61 to 4.06 ± 0.60 in
mg/dl, p=0.03) the FH+ group. Low density lipoprotein to high density lipoprotein ratio
also significantly improved (2.77 ± 0.48 to 2.42 ± 0.46 mg/dl, p=0.03) in the FH+ group
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Number of Subjects
Age
Height (cm)
Body weight (Kg)
BMI (kg/m2)
Body fat (%)
Body fat (kg)
Lean mass (kg)
Waist to Hip Ratio (WHR)
BMC (g)
BMD (g/kg2)
Tryglycerides (mg/dl)
Cholesterol (mg/dl)
High-density Lipoproteins (HDL)
Low-density lipoproteins (LDL)
Total Cholesterol/HDL
LDL/HDL Ratio
Fasting glucose (mg/dl)
Fasting glucose (mmol/l)
Fasting Insulin (mIU/L)
2h-OGTT (AUC)
3h-OGTT (AUC)
HOMA-IR (AU)
HOMA-β (AU)
QUICKI (AU)
Insulin sensitivity ((mg/kg EMBS/min)
Metabolic Flexibility ( RQ)
Resting Metabolic Rate (Kcal)
Resting Metabolic Rate (Kcal/FFM)
Resting Metabolic Rate (Kcal/BW)
Upper-body strength (Lbs)

Baseline
9
22.5±0.81
173.82 ± 1.46
79.34 ± 4.88
27.51 ± 1.68
29.04 ± 2.33
23.44 ± 3.03
54.82 ± 2.28
0.87 ± 0.01
3069.44 ± 133.72
1.23 ± 0.03
152.3 ± 21.87
142.8 ± 6.83
31.44 ± 2.21
79.56 ± 6.11
4.71 ± 0.35
2.62 ± 0.24
77.29 ± 1.95
4.29 ± 0.10
12.9 ± 2.45
247.4 ± 11.90
307.1 ± 6.14
2.51 ± .51
358.7 ± 67.73
0.34 ± 0.01
2.995 ± .27
0.07 ± 0.01
2077 ± 119.5
37.6 ± 1.16
25.2 ± 0.81
155.0 ± 20.83

FH-

Basline vs 8-weeks
p-value

0.0008***
0.38
0.08
0.98
0.02*
0.18
0.87
0.89
0.71
0.27
0.03*
0.8
0.3
0.31
0.81
0.81
0.02*
0.29
0.93
0.03*
0.02*
0.69
0.02*
0.71
0.99
0.6
0.96
0.0001****

Baseline
10
23.9±0.85
174.24 ± 1.46
79.00 ± 2.81
26.63 ± 1.02
31.63 ± 2.06
24.23 ± 1.97
51.14 ± 1.58
0.86 ± 0.01
2945.67 ± 127.60
1.23 ± 0.04
133.0 ± 21.05
159.8 ± 12.85
38.3 ± 3.47
95.0 ± 11.41
4.56 ± 0.61
2.76 ± 0.48
80.48 ± 1.70
4.47 ± 0.09
9.62 ± .87
302.4 ± 11.01
354.1 ± 13.5
1.92 ± 0.19
213.3 ± 24.93
0.35 ± 0.00
3.63 ± .50
0.08 ± 0.01
1966 ± 50.62
38.6 ± 1.27
24.9 ± 0.72
148.5. ± 16.87

FH+
8-Weeks
10

79.66 ± 2.57
26.70 ± 1.01
30.01 ± 1.9
23.21 ± 1.82
53.42 ± 1.8
0.84 ± 0.01
3034.0 ± 120.1
1.23 ± 0.04
113.30 ± 20.4
152.60 ± 11.61
41.1 ± 3.47
88.70 ± 9.51
4.05 ± 0.60
2.41 ± 0.46
80.33 ± 1.50
4.46 ± 0.08
9.53 ±1.09
237.5 ± 11.77
323.9 ± 14.61
1.88 ± 0.21
217.3 ± 32.97
0.35 ± 0.00
4.82 ± 0.51
0.11 ± 0.02
2061 ± 87.36
38.9 ± 1.52
25.4 ± 0.81
178.00 ± 16.75

Basline vs 8-weeks
p-value

0.44
0.94
0.005**
0.1
0.001**
0.26
0.13
0.46
0.18
0.35
0.09
0.31
0.03*
0.03*
0.99
0.99
0.99
0.002**
0.09
0.97
0.99
0.86
0.002**
0.24
0.33
0.95
0.8
0.0001****
0.0003***
0.01**
0.001***
0.88

FH- vs FH+
Pre-intervention

0.25
0.35
0.95
0.65
0.41
0.82
0.19
0.56
0.5
0.86
0.53
0.27
0.12
0.26
0.84
0.8
0.23
0.23
0.2
0.0002***
0.007**
0.28
0.051
0.84
0.3
0.72
0.29
0.57
0.82
0.8
0.96
0.47
0.25
0.068
0.48

Group Effect

Time Effect

Interaction Effect

0.02*
0.47
0.43
0.14
0.48
0.83
0.33
0.64
0.09
0.059
0.69
0.17
0.44
0.46
0.62
0.62
0.06
0.02*
0.04*
0.09
0.058
0.82
0.5
0.59
0.4
0.4
0.56
0.47

p-value

0.0009***
0.26
0.001***
0.19
0.0001****
0.03*
0.11
0.28
0.5
0.86
0.00***
0.59
0.01**
0.01**
0.73
0.73
0.052
0.0003***
0.1
0.055
0.07
0.37
0.0002***
0.12
0.27
0.65
0.8
0.0001****

0.94
0.26
0.18
0.18

p-value

0.81
0.6
0.45
0.94
0.21
0.62
0.62
0.89
0.25
0.53
0.13
0.37
0.71
0.89
0.22
0.22
0.37
0.01**
0.23
0.45
0.1
0.88
0.17
0.38
0.4
0.32
0.96
0.85

0.0001****
0.005**
0.0005***
0.44

p-value

0.94
0.65
0.44
0.81
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8-weeks
9

81.95 ± 4.88
27.81 ± 1.64
27.97 ± 2.28
23.51 ± 3.08
56.52 kg ± 1.87
0.85 ± 0.01
3092.3 ± 151.1
1.24 ± 0.03
161.1 ± 20.42
151.3 ± 8.89
35.00 ± 2.36
82.33 ± 5.68
4.42 ± 0.27
2.42 ± 0.19
78.10 ± 1.43
4.34 ± 0.07
10.12 ± 1.59
227.5 ± 6.60
302.1 ± 16.25
1.97 ± 0.32
246.4 ± 33.8
0.35 ± 0.00
3.88 ± 0.28
0.09± 0.01
2074 ± 61.05
36.6 ± 1.00
25.0 ± 1.06
181.1 ± 21.13

Lower-body strength (Lbs)
354.4 ± 31.98
416.7 ± 27.55
0.0006***
356.00 ± 20.18
419.50 ± 15.99
Aerobic Fitness (ml/kg/min)
46.25 ± 1.55
47.51 ± 0.98
0.33
44.48 ± 1.82
47.18 ± 2.00
Aerobic Fitness (L/min)
3.84 ± 0.23
3.97 ± 0.21
0.11
3.57 ± 0.16
3.82 ± 0.16
Fasting Substrate Utilizarion (RQ)
0.28
0.71 ± 0.01
0.72 ± 0.01
0.72 ± 0.01
0.69 ± 0.02
Physical Activity Level (PAL)
0.38 ± 0.17
0.69 ± 0.44
ANOVA p<0.05*, p<0.01**, p<0.001***, p<0.0001****; T-test Kcal/FFM- Kilocalories/Fat Free Mass; Kcal/FFM- Kilocalories/Body Weight.

Table 7.

Improvement in Insulin Sensitivity after 8-Weeks of Combined Exercise Training
Insulin sensitivity significantly improved in both groups (FH- 2.99 ± 0.27 to 3.89 ±
0.28 mg/kg EMBS/min, p=0.02; FH+ 3.63 ± 0.50 to 4.82 ± 0.51 mg/kgEMBS/min,
p=0.002, Figure 2A) after 8-weeks of combined exercise training. Change in insulin
sensitivity between FH- and FH+ did not differ when expressed as delta (D) (FH- 0.89 ±
.25 ml/kg/EMBS; FH+ 1.19 ± 0.35 ml/kg/EMBS, p=0.50 (Figure 2B) or percent change
(FH- 34.90 ± 11.00% vs. FH+ 40.66±12.19%; p>0.05, Figure 2C).

A

B

C

Figure 2 (A). Healthy normoglycemic individuals with (FH+) and without (FH-) a family history of type 2
diabetes significantly improved insulin sensitivity after 8-weeks of combined exercise training. (B).
Individuals with (FH+) and without (FH-) a family history of type 2 diabetes did not differ in terms of
change in insulin sensitivity. (C). Individuals with (FH+) and without (FH-) a family history of type 2
diabetes did not differ in improvement of insulin sensitivity.
EMBS: Estimated Metabolic Body Size, Data are means ± SEM. *p<0.05, **p<0.01
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No change in Metabolic Flexibility after 8-Weeks of Combined Exercise Training
Metabolic flexibility, measured by change in respiratory quotient (DRQ) from
fasting to insulin stimulated condition, did not change after 8-weeks of combined
exercise training in participants without a family history of T2D (FH- 0.07 ± 0.01 to 0.09
± 0.01, p=0.71; FH+ 0.08 ± 0.01 to 0.11 ± 0.06, p=0.24; Figure 3A). No change in
metabolic flexibility was present in either group when expressed as delta (FH- 0.07 ±
0.01 to 0.09 ± 0.01, p=0.71; FH+ 0.08 ± 0.01 to 0.11 ± 0.02, p=0.24; Figure 3B).
Metabolic flexibility did not change when expressed as percent change (FH- 9.97 ± 2.27
to 12.73 ± 2.69, p=0.47; FH+ 10.72 ± 1.93 to 15.81 ± 3.05, p=0.14; Figure 3C) Fasting
substrate utilization did not change (FH- 0.72 ± 0.00 to 0.69 ± 0.01, p=0.07; FH+ 0.71 ±
0.01 to 0.71 ± 0.01, p=0.68; Figure 3D). Resting energy expenditure did not improve
(FH- 2077.32 ± 119.5 to 2173.00 ± 61.05, p=0.99; FH+ 1965.0 ± 50.62 to 2061.40 ±
87.36, p=0.33; Figure 3E).
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Change in Metabolic Flexibility
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Figure 3(A). Healthy normoglycemic individuals with (FH+) and without (FH-) a family history of type 2
diabetes significantly ncreased respiratory quotient from fasting conditions to insulin stimulated
conditions during pre and post intervention clamps. (B). Metabolic flexibility did not change in either
group after 8 weeks of combined exercise. (C). Metabolic flexibility percent change remained unchanged
for both groups. (D). Fasting substrate utilization did not change in either group. (E). Resting energy
expenditure did not chage in either group. **p<0.001,***p<0.0001. ****p<0.001. Data are means ± SEM.
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Improvement in Performance after 8-Weeks of Combined Exercise
Upper body strength, measured by flat barbell bench press significantly
increased for both groups (FH- 155.00 ± 20.83 to 181.10 ± 21.13 lb, p=0.0001; FH+
148.50 ± 16.87 to 178.00 ± 16.75lb, p=0.0001; Figure 4A) after eight weeks of
combined aerobic and resistance exercise training. Increase in upper body strength
between FH- and FH+ groups were not different after 8-weeks of combined exercise
training when expressed as delta (FH- 26.11 ± 2.97 lb vs. FH+ 29.50 ± 3.45 lb; p=0.47;
Figure 4C ) or percent change (FH- 19.28 ± 3.45 % vs. FH+ 22.59 ± 3.73 %; p=0.52,
Figure 4E).
Lower-body strength, measured by Lower-body dynamometer increased
significantly for both groups (FH- 354.44 ± 31.97 to 416.67 ± 27.55 lb, p=0.0006; FH+
356.00 ± 20.17 to 419.50 ± 15.99 lb, p=0.0003; Figure 4B) after 8-weeks of combined
exercise. Increase in lower body strength between FH- and FH+ groups were not
different after 8-weeks of combined exercise training when expressed as delta (FH62.22 ± 17.71 lb vs. FH+ 63.50 ± 8.50 lb; p=0.94; Figure 4C) or percent change (FH21.95 ± 8.23 % vs. FH+ 19.36 ± 3.69 %; p=0.76, Figure 4F.
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A

B

C

D

E

F

Figure 4 (A). Healthy normoglycemic individuals with (FH+) and without (FH-) a family history of type 2 diabetes
significantly increased upper body strength after 8 weeks of combined exercise training. (B). Individuals with (FH+)
and without (FH-) a family history of type 2 diabetes significantly increased lower body strength. (C). Subjects did not
differ in terms of change (D) increase in upper body strength. (D). Subjects did not differ in terms of change (D) in
crease in lower body strength delta. (E). Subjects did not differ in terms of percent change (%) in upper body strength.
(F). Subjects did not differ in terms of percent change (%) in lower body strength. **p<0.001,***p<0.0001.
****p<0.00001, Data are means ± SEM.
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Improvement in Aerobic Fitness after 8-weeks of Combined Exercise Training
Aerobic fitness significantly increased in the FH+ group (3.57 ± 0.16 to 3.82 ± 0.16
L/min p=0.001; Figure 5A; 44.48 ± 1.82 to 47.18 ± 2.00 ml/kg/min p=0.01; Figure 6A)
while the FH- group did not improve aerobic fitness (3.84 ± 0.23 to 3.97 ± 0.21 L/min
p=0.11; Figure 5A; 46.25 ± 1.55 to 47.51 ± 0.98 ml/kg/min p=0.33; Figure 6A) after 8
weeks of combined exercise training. Increase in aerobic fitness between FH- and FH+
groups were not different after 8-weeks of combined exercise training when expressed
as delta (FH- 0.13 ± 0.07 L/min vs. FH+ 0.25 ± 0.05 L/min; p=0.18; Figure 5B; 1.26 ±
0.98 ml/kg/min vs. 2.70 ± 0.79 ml/kg/min, p=0.46 Figure 6B) or percent change (FH3.98 ± 2.03 % vs. FH+ 7.39 ± 1.54 % L/min; p=0.19; Figure 5C; FH- 3.27 ± 2.43% vs.
FH+ 6.19 ± 1.83 % ml/kg/min; p=0.34, Figure 6C).
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A

B

C

Figure 5. (A). Healthy normoglycemic individuals with (FH+) a family history of type 2 diabetes significantly increased
aerobic fitness after 8-weeks of combined exercise training. (B). Healthy normoglycemic individuals with (FH+) and
without (FH-) a family history of type 2 diabetes did not differ in terms of change (D) improvement in aerobic fitness.
(C). Individuals with (FH+) and without (FH-) a family history of type 2 diabetes did not differ in terms of percent
change (%) improvement in aerobic fitness. ***p<0.001, Data are means ± SEM.

A

B

C

Figure 6 (A). Healthy normoglycemic individuals with (FH+) a family history of type 2 diabetes significantly improved
aerobic fitness after 8-weeks of combined exercise training. (B). Individuals with (FH+) and without (FH-) a family
history of type 2 diabetes did not differ in terms of change (D) in aerobic fitness. (C). Individuals with (FH+) and
without (FH-) a family history of type 2 diabetes did not differ in terms of percent change (%) in aerobic fitness.
*p<0.05, Data are means ± SEM.

37

Improvement in Body Composition after Eight Weeks of Combined Exercise
Body weight significantly increased in the FH- group (FH- 79.34 ± 4.88 to 81.95 ±
4.88 kg, p=0.0008; Figure 7A). Increase in body weight between FH- and FH+ groups
after 8-weeks of combined exercise training when expressed as delta was significantly
higher in the FH- group compared to the FH+ group (FH- 2.61 ± 0.64 kg vs. FH+ 0.66 ±
0.50 kg; p=0.02; Figure 8A). Increase in body weight expressed as percent change had
a significnalty higher increase in the FH- group (FH- 3.42 ± 0.80 % vs. FH+ 0.95 ± 0.68
%; p=0.03; Figure 9A). Percent body fat significantly decreased in the FH+ group (FH+
31.63 ± 2.06 to 30.01 ± 1.9 %, p=0.005 Figure 7B) and displayed a trend to decrease in
the FH- group (FH- 29.04 ± 2.33 to 27.97 ± 2.28 kg, p=0.08 Figure 7B) after 8-weeks of
combined exercise training. Lean mass significantly increased after 8-weeks of
combined exercise training (FH- 54.82 ± 2.28 to 56.52 ± 1.87 kg, p=0.02, FH+ 51.14 ±
1.58 to 53.42 ± 1.8 kg, p=0.001; Figure 7C). After 8-weeks of combined exercise
training there were no changes in fat mass (FH- 23.44 ± 3.03 to 23.51 ± 3.08 kg,
p=0.98, FH+ 24.23 ± 1.97 to 23.21 ± 1.82 kg, p=0.10; Figure 7D)
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Figure 7. (A). Healthy normoglycemic individuals without (FH-) a family history of type 2 diabetes
significantly increased total body weight after 8-weeks of combined exercise training. (B). Percent body fat
significantly decreased in the FH+ group. (C). ). Individuals with (FH+) and without (FH-) a family history of
type 2 diabetes significantly increased Lean mass (D). No changes in fat mass was observed in either
group. *p<0.05, **p<0.01, ***p<0.001. Data are means ± SEM.
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Figure 8 (A). Increase in body weight between FH- and FH+ groups when expressed as delta were not significantly
different after 8-weeks of combined exercise training. (B). No difference in delta body fat % decrease between
groups. (C). No difference in delta lean mass increase between groups was observed. (D). No difference in delta fat
mass decrease between groups was observed after 8-weeks of combined exercise training. *p<0.05, Data are
means ± SEM.
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Figure 9. (A) Increase in body weight expressed as percent change were significantly different between groups with
the FH- group having a significant increase after 8-weeks of combined exercise training. (B). No difference in percent
change decrease in body fat % between groups. (C). No difference in percent change lean mass increase between
groups. (D). No difference in percent change fat mass between groups. *p<0.05, Data are means ± SEM.

40

IL-6 Secretion after Exercise Training
Il-6 plasma concentrations from pooled samples that included all baseline time
points for the FH- group appear to have been regulated (18.37 to 5.94 pg/ml) after 8
weeks of combined exercise training (chronic effect of exercise). FH+ individuals
displayed virtually identical IL-6 plasma concentrations after 8-weeks of combined
exercise training (11.58 to 11.49 pg/ml) compared to baseline. The effect of an acute
bout of aerobic training at baseline, displayed minimal change in circulating IL-6 in the
FH- group (7.5 to 6.85 pg/ml). An acute bout of resistance training at baseline displayed
a potential regulation of circulating IL-6 (8.74 to 6.96 pg/ml) in the FH- group; as well as
in the FH+ group (7.03 to 10.05 pg/ml) after 8-weeks of combined exercise training.
Lastly, plasma IL-6 concentrations in the FH- group after an acute bout of resistance
training following 8-weeks combined exercise appears to be unaltered (6.91 to 7.01
pg/ml); while the FH+ group displayed a regulatory effect after exercise (11.95 to 16.02
pg/ml).

Figure 10. Chronic and acute effects of 8 weeks of combined exercise
training on IL-6 pooled plasma concentrations.
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IL-15 Secretion after Exercise Training
Plasma concentrations of IL-15 were below the detectable range in pooled
samples in all conditions for the FH- group. Plasma IL-15 concentrations were only
detectable at baseline for the FH+ group (3.65 pg/ml).

Figure 11. IL-15 pooled plasma concentrations were detectable only at
baseline for the FH+ group.

IL-8 Secretion after Exercise Training
IL-8 plasma concentrations may have been regulated (19.84 to 7.06 pg/ml) in the
FH- group after 8 weeks of combined exercise training (chronic effect of exercise). FH+
individuals displayed a potential upregulation in IL-8 plasma concentrations after 8weeks of combined exercise training (11.24 to 12.66 pg/ml). The effect of an acute bout
of aerobic training on IL-8 secretion before 8-weeks of combined exercise training may
have not elicited a change on the FH- group, (7.75 to 7.98 pg/ml) as well as (13.47 to
12.49 pg/ml) in the FH+ group. An acute bout of resistance training before the 8-weeks
of combined exercise training appeared to have regulated circulating IL-8 (11.02 to 8.88
pg/ml) in the FH- group; while the FH+ group’s circulating IL-8 may have also been
regulated by exercise (9.65 to 6.25 pg/ml) in IL-8 secretion after 8-weeks of combined
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exercise training. Circulating IL-8 in the FH- group may have not been impacted after an
acute bout of aerobic exercise after 8-weeks of combined exercise training (7.61 to 6.99
pg/ml). Circulating IL-8 in the FH+ group may have been regulated by an acute bout of
aerobic exercise after 8-weeks of combined exercise training (8.26 to 12.25 pg/ml).
Lastly, plasma IL-8 concentrations in the FH- group after an acute bout of resistance
remained unchanged following 8-weeks combined exercise training (7.63 to 8.14 pg/ml);
while it may have been regulated in the FH+ group (12.02 to 15.45 pg/ml).

Figure 12. Chronic and acute effects of exercise training on IL-8 pooled
plasma concentrations after 8-weeks of combined exercise.
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Myostatin Secretion after Exercise Training
Myostatin pooled plasma concentrations were below the detectable range in
samples at all time points for the FH- group. Myostatin concentrations appear to have
been regulated after 8-weeks of combined exercise training (4553.0 to 494.02 pg/ml) in
the FH+ group. Myostatin levels were also below baseline levels before an acute bout of
aerobic exercise (473.53 pg/ml) before the 8-week exercise intervention, after an acute
bout of resistance training (469.62 pg/ml), and before an acute bout of resistance
training (500.17 pg/ml) after the 8-week exercise intervention.

Figure 13. Myostatin pooled plasma samples after 8-weeks of combined exercise
training.
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Oncostatin M Secretion after Exercise Training
The effect of an acute bout of aerobic training on Oncostatin M (OSM) secretion
before 8-weeks of combined exercise training displayed no regulation induced by
exercise in the FH- group, (11.58 to 12.01 pg/ml) and a potential regulation in the FH+
group (5.96 to 11.2 pg/ml). An acute bout of resistance training before the 8-weeks of
combined exercise training may have also regulated circulating OSM (17.24 to 8.69
pg/ml) in the FH- group as well as in the FH+ group (11.69 to 9.54 pg/ml) after 8-weeks
of combined exercise training. Although sample replicate variability was evident,
circulating OSM appears to have not been impacted (6.41 to 5.11 pg/ml) in the FHgroup after an acute bout of aerobic exercise. The FH+ group also may have
experienced a regulatory effect in circulating OSM concentrations after an acute bout of
aerobic exercise following 8-weeks of combined exercise training (17.13 to 9.43 pg/ml).
Lastly, plasma OSM concentrations in the FH- group appear to have been regulated
(5.81 to 8.85 pg/ml) after an acute bout of resistance training following 8-weeks
combined exercise. A change in OSM after 8-weeks of combined exercise could not be
determined because the concentrations were below the detectable range.

Figure 14. Regulatory effects of exercise on OSM after 8 weeks of combined
exercise training.

45

Chapter 4: Discussion
Given that the prevalence of T2D has more than doubled within the last 20
years (cdc.gov, 2017), a coherent understanding of factors contributing to the
development of T2D is necessary to prevent/cure the disease. Additionally, MexicanAmericans are at a greater risk for developing T2D compared to non-Hispanic
whites (CDC, 2016). The present study provides valuable insight and helps fill the gap
in literature concerning the implications of FH+ in Mexican-Americans in regard to
insulin resistance, metabolic flexibility and myokine concentrations compared to FHindividuals. To the best of our knowledge, this is the first study to report that young,
normoglycemic Mexican-Americans with FH+ improved insulin sensitivity, body
composition, and muscle strength after combined exercise training to the same extent
as FH- individuals. The primary finding of this study is that following an 8-week
combined exercise training intervention, exercise induced improvements in body
composition, and insulin sensitivity were not impacted by a family history of T2D in
young, healthy normoglycemic Mexican-American men. Furthermore, a comparable
insulin sensitivity, metabolic flexibility, resting energy expenditure, substrate utilization,
and body composition between FH- and FH+ indicates that no metabolic defects were
present in a healthy, young, Mexican-American population. The present study is one of
a few to investigate the insulin sensitizing effects of exercise in young FH- and FH+
Mexican-Americans [46, 87].
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Insulin Sensitivity
In the current study insulin sensitivity was assessed using the gold standard
method, the hyperinsulinemic-euglycemic clamp [85], to determine the effects of FH+ on
insulin sensitivity in a normoglycemic, healthy young Mexican-American population.
Several studies indicate a lower insulin sensitivity in FH+ compared to FH- [3-10, 12, 13,
15, 88-90] whereas some report no difference in insulin sensitivity between FH- and
FH+ [11, 16, 91]. The majority of these studies measure insulin sensitivity by HOMA-IR
[4, 6, 90] QUIKI [12], or OGTT [4, 5, 8-10, 13, 15, 89, 91] whereas some studies
measured insulin sensitivity using the clamp [3, 7, 13, 15, 88]. Gulli et al., 1992 was one
of three studies that measured Insulin sensitivity in the Mexican-American population
and reported a lower in insulin sensitivity in the FH+ group compare to FH- measured by
the clamp. Gulli et al., (1992) reported to have only included 2 males compared to 9
females in the FH+ group as well as only 1 male compared to 9 females in the FHgroup. Similarly, Ryder et al., (2002) found that Mexican-Americans with a first degree
family history of T2D possessed increased insulin resistance and a low disposition
index, which can account for increased insulin secretion to compensate for decreased
insulin sesitivity, and together can help predict the progression of insulin resistance to
T2D. Further, Civitraese et al., (2004) utilized clamp method to assess insulin sensitivity
in FH- and FH+ Mexican-Americans, determined that FH+ had a significantly decreased
insulin sensitivity compared to the FH- group [88]. Similarly, Pratipanawatr et al., (2001),
also assessed insulin sensitivity in FH- and FH+ Mexican-Americans and Caucasians
through the clamp and demonstrated that FH+ subjects had decreased insulin
sensitivity compared to the FH- group [89]. Gulli et al., (1992) demonstrated that FH+ in
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Mexican-American individuals had significantly lower glucose disposal rates (GDR)
during a two-step clamp performed at 20 and 40-mU/min-1/m2 to elicit plasma insulin
levels approximately to half maximal stimulation of total glucose disposal [15]. Our
findings do not align with those reported by Gulli et al., (1992). Gulli et al. focused on
the Mexican-American population consisting of mainly females, whereas our study was
also conducted in Mexican-Americans but only examined the male population. As
described by Kennedy et al., (1997), gender based differences such as insulin
sensitivity may have been impacted by the lopsided number of male vs female subjects.
Given that Insulin sensitivity is altered by different stages of the menstrual cycle and
that contraceptives have shown to impact Insulin sensitivity negatively, the use of only
male subjects will yield data that is not influenced by fluctuating hormone levels [90].
Gender based differences may have contributed towards difference in study outcomes
[91]. Additionally, the FH+ group studied by Gulli et al., (1992) was on average older
than the FH+ group in our study. As described by Pick et al., 1998, chronic
hyperglycemia may lead to compensatory over secretion of insulin to enhance glucose
uptake, which in turn is one of the hallmarks of insulin resistance. Therefore, older
individuals may have a longer amount of time in the hyperglycemic state thus
exacerbating insulin resistance. Our results suggest that insulin sensitivity is not
impacted by a family history of T2D in young Mexican-American males. Our findings are
in line with those of Ukropcova et al., (2007) who investigated the impact of FH+ in
Caucasians, African-Americans, and Asians as well as findings from Heilbronn et
al., (2007), who investigated the impact of FH+ in Caucasians [11]. Similar to our study,
Ukropcova et al., (2007) measured insulin sensitivity by hyperinsulinemic-euglycemic

48

clamp and reported no difference in insulin sensitivity between FH- and FH+ in their
target population of young Caucasians, African-Americans, and Asians. Similarly,
Heilbronn et al., (2007) also assessed insulin sensitivity using the hyperinsulinemiceuglycemic clamp and reported no difference in insulin sensitivity between FH- and
FH+. Moreover, our study used a much greater dose of insulin infusion (80 mu/min/m2)
for greater suppression of hepatic glucose production during the hyperinsulinemiceuglycemic clamp [85]. Key reasons for the disparities in the literature to the results of
our study can be explained by several factors. First, the insulin signaling cascade may
take a longer time to be disrupted by chronically elevated levels of blood glucose which
will increase insulin secretion by the b-cells of the pancreas [92]. Over time these
increased levels of circulating insulin combined with the negative feedback loop, may
lead to disturbances of IRS-1 receptors on the cell which have been shown to impact
glucose homeostasis [89, 93] Secondly, given that insulin resistance is partly driven by
diminished b cell function, a consequence of chronic hyperglycemia, middle aged
individuals, such as those studied by Pratipanawatr et al., (2001), Civitarese et al.,
(2004), and Gulli et al., (1992) may have had more time to exhaust the b cells of the
pancreas as they aged [92]. Younger individuals regardless of Family history if T2D may
not have had an ample amount of time in the hyperglycemic state to exacerbate IR.
Furthermore, elevated levels of blood glucose over extended periods of time, can lead
to high compensatory rates of insulin secretion by the pancreas which can lead to b-cell
failure [15, 94]. While insulin sensitivity appears to be altered following exercise training,
this effect may be altered in those with a family history of T2D and requires further
exploration to fill gaps in the literature.
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Exercise Induced Improvements
The insulin sensitizing effects of exercise have been studied extensively in
healthy, obese, T2D and, FH+ individuals [18, 40, 48, 49, 95, 96]. Given that skeletal
muscle comprises ~40% of total body mass in humans, skeletal muscle mass
possesses a major role in glucose metabolism and insulin action. Skeletal muscle is
regarded as the main tissue responsible for peripheral glucose disposal during an oral
glucose tolerance test, hyperinsulinemic-euglycemic clamp as well during exercise [85].
After 8-weeks of combined exercise training, both groups improved insulin sensitivity.
Given that a significant increase in muscle mass was evident in both groups, and that
skeletal muscle plays a major regulatory role in glucose metabolism, higher GDR values
accompanied by an increase in muscle mass may have made full use of their symbiotic
relationship to enhance insulin sensitivity after exercise training [58, 60]. To account for
the influence of increased muscle mass on insulin sensitivity, GDR was normalized by
lean mass. After GDR normalization, our findings demonstrate that 8-weeks of
combined exercise training was effective and can be used as a means to improve whole
body insulin sensitivity. In a similar study that implemented 12 weeks of combined
exercise training in a healthy population as well as patients with T2D, Meex et al.,
(2010) demonstrated a significant improvement in insulin sensitivity in T2D subjects
[18]. Furthermore, in line with our findings in FH+ individuals, Jorge et al., (2011),
demonstrated that T2D individuals were also able to achieve significant improvements
in insulin sensitivity following 12 weeks of combined exercise training. A 6-month
exercise intervention conducted by Wing et al., (1998), reported that individuals with
FH+ significantly decreased body weight, BMI, fasting plasma glucose, and insulin.
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These findings suggest that both T2D individuals as well as FH+ individual are able to
reap the benefits of exercise after 8 weeks, 12 weeks, and 6 months of exercise
training, respectively. The multifaceted novelty of our study includes the meals
participants were provided with to control for diet in order to diminish the dietary effects
of high fat/carbohydrate consumption on insulin sensitivity. Further, to the best of our
knowledge, this is the first study to investgate the insulin sensitizing effects of combined
exercise training on FH- and FH+ healthy, young Mexican-Amercians.

Exercise Induced Effects on Metabolic Flexibility
Considerable data indicates that FH+ and T2yjD individuals’ exhibit diminished
metabolic flexibility during insulin stimulated conditions [7, 15, 17-19]. In support,
findings by Kelley et al., (2000), have shown that insulin-resistant skeletal muscle of
young to middle aged participants with T2D is characterized by diminished metabolic
flexibility. A study by Felber et al., (1987) demonstrated that obese and T2D subjects do
not suppress lipid oxidation during the insulin stimulated state of the clamp compared to
the normoglycemic control group. Additionally, Felber et al., (1987)., found that the 3
obese groups which were composed of individuals with normal glucose tolerance,
Impaired glucose tolerance, and type 2 diabetes, displayed lower levels of glucose
oxidation during an OGTT and clamp, indicating a higher oxidation of lipid compare to
the normoglycemic subjects. Our data indicate, that there were no differences in
metabolic flexibility between normoglycemic FH- and FH+ groups. In addition, there was
no difference between groups in terms of change in metabolic flexibility from pre to post
exercise intervention. In a similar study, Gulli et al., (1992) assessed metabolic flexibility
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in FH- and FH+ Mexican-American during a two-step clamp and reported metabolic
inflexibility in FH+ compared to FH-. Furthermore, Menshicova et al., (2007), conducted
a 16-week study in which obese and lean endurance trained participants exercised
aerobically for 30 minutes between 60-75% of VO2max. Sixteen weeks of exercise
intervention increased fasting fat oxidation as well as suppression of fat oxidation during
the insulin stimulated state of the hyperinsulinemic euglycemic clamp, indicating an
improvement of metabolic flexibility [97]. In the current study, metabolic flexibility was
assessed at baseline and after 8-weeks of combined exercise training through indirect
calorimetry during fasted conditions and insulin stimulated conditions. Our findings do
not support data reported by Gulli et al., (1994) showing that metabolic flexibility is
impacted by a family history of T2D. Again, the explanation to why our data do not align
with that of Gulli et al., (1994), may be that on average, our Mexican-American subjects
were relatively younger and may already have a healthy metabolic flexibility. We
demonstrated that FH- and FH+ individuals had virtually identical RQ values during
fasted conditions and insulin stimulated conditions at baseline while metabolic flexibility
did not improve in either group after 8-weeks of combined exercise training.
Furthermore, RMR data obtained during the clamp indicated that there was no
statistically significant increase in caloric expenditure in either group from baseline to
after 8-weeks of combined exercise training. Given that our data indicates that subjects
in both groups had relatively normal RQ values (~0.70) at baseline and that both groups
responded to the insulin stimulation to the same extent, our subjects may have had
healthy/unimpaired metabolic flexibility. Therefore, there may have been minimal room
for improvement in their already healthy relatively low RQ [18, 98].
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Performance Enhancing Effects
The performance enhancing effects of combined exercise training have been
previously reported [51, 99]. A 13-week resistance, aerobic, and combined exercise
training study conducted by Glowacki et al., (2004), found that on average, upper body
strength measured through 1RM bench press increased 7.5%, 30.5%, and 21.2% in the
aerobic, resistance and combined exercise training groups, respectively. The exercise
intervention also elicited improvement in lower-body strength with 1RM leg press by
20.4%, 40.8%, and 39.4% in the aerobic, resistance, and combined exercise training
groups, respectively [99]. Additionally, absolute maximal aerobic capacity increased
two-fold in the aerobic training group (~8%) compared to the resistance (3.7%) and
combined exercise training groups (2.8%) [99]. Further, a study conducted by
Tokmakidis et al (2004) which included combined resistance and aerobic exercise,
demonstrated that both upper and lower body strength significantly increased after 4
and 16 weeks. Although our exercise intervention was 8-weeks in duration, we were
able to achieve comparable improvements in upper and lower body strength and
maximal aerobic capacity to that of Glowacki et al (2004). FH- and FH+ subjects in the
current study improved upper-body strength measured by 1RM bench press 19.28%
and 22.59%, respectively, while lower-body strength measured using a leg strength
dynamometer improved in both FH- and FH+ groups 21.95% and 19.36%, respectively.
In regard to improvements in absolute maximal aerobic capacity, the FH- group
improved 4.4% and the FH+ group improved 7.4% after 8-weeks of exercise training. To
the best of our knowledge, our data is the first to indicate that FH+ did not impact
exercise mediated improvements in upper and lower body muscular strength.
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Studies that investigate improvements in maximal aerobic capacity within
individuals with FH+ are limited. Leite et al., (2009), conducted a study that included at
risk individuals for T2D with FH+ who had hypertension, hyperinsulinemia, obesity,
impaired glucose tolerance, and dyslipidemia but not T2D. These individuals underwent
a maximal aerobic capacity exercise test and the most prevalent anomaly in the at risk
FH+ group was a diminished maximal aerobic capacity [100]. It was reported that a
lower VO2max significantly correlated with impaired insulin sensitivity [100]. Contrary to
Leite et al., (2009), our results indicated that FH- and FH+ had comparable absolute
and relative VO2max at baseline. In addition, although the FH+ group displayed an
increase in VO2max, the percent change improvement in VO2max was also comparable
between groups, indicating FH+ was not a limiting factor in exercise induced
improvements in aerobic capacity within our study. The conflict of findings can be the
difference in the mean age of our study participants being much younger compared to
those reported in Leite et al (2009). Furthermore, a compromised lipid oxidation, such
as that evident in those with metabolic diseases may also contribute to a diminished
VO2max ([18]. In our study defects in lipid oxidation were not evident. Further, we were
able to show that there were no differences in lipid oxidation between the FH- and FH+
groups. Our findings also help gain a better understanding of combined exercise
prescription necessary to help individuals yield improvements in maximal aerobic
capacity.
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Improvements in Body Composition
Combined exercise training has previously been reported to be effective in
improving body composition [38, 45, 47]. Lucotti et al., (2011), incorporated a 3-week,
aerobic (15-minute row ergometer & 15 minute of bicycle ergometer) and combined (5
upper-body and 4 lower-body exercises) exercise training intervention that included an
aerobic training group and a combined exercise training group. Decreases in body
weight and fat mass were reported in both groups after the 3-week exercise intervention
[38]. Similarly, Tan et al., (2012) reported that T2D subjects who participated in a 6month combined exercise training program significantly decreased their body fat
percentage compared to the control group which did not exercise. In line with our study,
Van Der Heijden et al., (2010) reported that after a 10-week resistance exercise
program subjects significantly increased FFM. Our results show that both FH- and FH+
groups had virtually identical body composition values in terms of body weight and body
fat %. Additionally, the FH- group significnaly increased body weight and had a
significantly higher increase in body weight (delta) compared to the FH+ group after
combined exercise training. Furthermore, we show that combined exercise training
elicited an increase in FFM in both groups following 8-weeks of combined exercise
training. To the best of our knowledge this is the first study to report that a family history
of T2D does not impact exercise induced gains in FFM and strength.
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Effects of Exercise on Myokines
Our exploratory aim, which investigated the effects of exercise on circulating
concentrations of myokines and cytokines before and after acute bouts of aerobic,
resistance exercise, and after 8-weeks of combined exercise training between FH- and
FH+ individuals helps shed light on potential beneficial effects of combined exercise
training. Given that the current study pooled plasma samples, statistical testing was not
feasible and was not carried out. Our findings indicate that after 8-weeks of combined
exercise training circulating IL-6 appears to have been downregulated in the FH- group
which displayed varying concentrations in circulating IL-6 post intervention, while IL-6
concentration in the FH+ remained stagnant. Although we did not measure transcript
variants, Oberbach et al., (2008) found that after 12 months of exercise the 174G/C
variant in the IL-6 gene, which is responsible for IL-6 transcription, significantly reduced
IL-6 serum concentrations [101]. Conversely, Kim et al., (2014), conducted a study
incorporating combined exercise training 3 times per week for 12 weeks and found that
when compared to the aerobic exercise training group the individuals partaking in
combined exercise had a significantly lower serum IL-6 concentrations. While IL-6
appears to be altered following exercise training, this effect may be altered in those with
a family history of T2D and requires further exploration.

Pooled serum IL-8 concentrations were shown to have been potentially regulated
in the FH- and FH+ groups after 8 weeks of combined exercise training. As previously
shown by Troseid et al., (2009), IL-8 was demonstrated to be significantly reduced after
8 weeks of combined aerobic and resistance exercise training and accompanied by
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significant improvements in maximal aerobic capacity [102]. IL-8 is known to aid in the
promotion of angiogenesis and could serve as a possible explanation to the
improvements in maximal aerobic capacity by improving circulation and subsequently
oxygen delivery to working muscles observed in our participants [103]. While the acute
bouts of exercise appear to cause alterations in IL-8 in FH+ individuals and is also
accompanied by similar improvements in delta and percent change aerobic capicty in
both groups, there appears to be a possible divergence in circulating IL-8 between the
groups. Such alterations in IL-8 release and signaling in FH+ individuals warrants
further investigation.

OSM has shown to positively impact insulin resistance, fat mass, and glucose
tolerance [104]. Our findings, which demonstrated a potential downregulation of OSM in
the FH- and FH+ groups following 8-weeks of combined exercise align with the
proposed effects of OSM reported by Komori et al., (2013). OSM concentrations may
have been influenced by the combined exercise training intervention and improvements
in insulin sensitivity which were observed in both FH- and FH+ groups. Furthermore,
Komori et al., (2013), demonstrated that there was an inverse relationship between
OSM and fasting insulin and AUC during an oral glucose tolerance test which does not
align with our findings. Despite the regulatory effects of exercise on OSM after 8-weeks
of combined exercise training, a significant decrease in glucose AUC after a 2-h OGTT
test was observed in the FH+ group and a significant decrease in fasting insulin in the
FH- group after 8-weeks of combined exercise training.
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Circulating IL-15 concentrations were only obtained for the FH+ group at baseline
(3.65 pg/ml). After exercise and collection, our blood samples were chilled on ice from
90-minutes (pre-exercise sample) to 15-minute (post-exercise samples). This variability
in processing time may have influenced different myokines to degrade at different rates.
Thus, providing an explanation to why some of our myokine assays detected ample
amounts of myokine concentrations at different time points and others did not.
Furthermore, given that IL-15 appears to be modified in the FH+ group following
combined exercise training, this regulatory effect may be different than in FHindividuals and therefore requires further exploration.

According to Jackman et al., (2011), the age of the sample at the time of
processing and freezing can impact the concentration of myokines. Additionally, future
studies should consider employing high sensitivity kits, which are more susceptible to
detect any changes or degradations in myokine concentrations compared to standard
sensitivity kits that were used in our analyses.

Myostatin, a myokine known for its regulatory effects on lean muscle mass was
only detected in the FH+ group, in which a robust regulatory effect was elicited following
8-weeks of combined exercise training. Our findings are in agreement with those of Kim
et al., (2005), in which it was demonstrated that as little as 5 sessions of resistance
training were effective in decreasing myostatin gene expression by 44%. Furthermore,
Hittel et al., (2010), demonstrated that 6-months of aerobic training was effective in
significantly decreasing circulating myostatin concentrations. Given that myostatin
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appears to be modified in the FH+ group following 8 weeks of combined exercise
training, this regulatory effect may be altered in those with a family history of T2D and
requires further exploration.

59

Limitations
A limitation of our study can be the self-reported non-diabetic parental status in
the FH- group, considering that about 25% of the diabetic population is undiagnosed
(CDC, 2017). However, we have scrutinized this information to the best of our
knowledge including confirmation with parents and when possible assessing fasting
plasma glucose. Although all study participants received a controlled diet for 5 days
prior to pre and post intervention testing, food consumption was not supervised. Given
that higher amounts of dietary fat consumption alter insulin sensitivity [105], we cannot
ignore the possibility of not fully adhering to the prescribed diet of all study participants.
Lastly, the variable blood processing time may have influenced the results in regard to
the exploratory aim and may help us understand optimal blood processing time and
conditions to ensure that accurate results are derived.
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Conclusion
In summary, we show that a family history of T2D does not impact exercise induced
improvements in insulin sensitivity in young healthy Mexican-Americans. This supports
the notion that exercise can serve as a powerful tool to combat insulin resistance, a
precursor to T2D, regardless of a family history of T2D in young normoglycemic
population. We also demonstrated that 8-weeks of combined exercise training is
effective in improving upper and lower body strength, fat free mass, and body fat %
regardless of a family history if T2D. Future studies should explore the mechanisms
associated with insulin resistance in different age groups to account for the longer
cumulative time older individuals have to exacerbate the disease by living in a chronic
state of hyperglycemia and potentially paving the way to b cell exhaustion.
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Appendix A
Table 1. Literature Overview- Effects of Family History of Type 2 Diabetes on Insulin
Sensitivity
Study

Status

Petersen et al.
2004

Insulin
Resistant &
Insulin
Sensitive
Normoglycemic

Method

Outcome

Age

Sex

One parent or
grandparent

HyperinsulinemicEuglycemic
Clamp

¯ IS in FH+

25-29

8m/18F

NA

First-degree
relative

Hyperinsulinemic
euglycemic clamp

¯ IS in FH+

19-41

28M/50F

White

HeilBronn et
al. 2007

Normoglycemic

First-degree
relative

Hyperinsulinemic
euglycemic clamp

No
Difference

34-52

5M/12F

White

Arslanian et al.
2005

Normoglycemic

First-degree
relative

Hyperinsulinemic
euglycemic clamp

¯ IS in FH+

11-12

25M/29F

White

Groop et al.
1996

Normoglycemic

First-degree
relative

Hyperinsulinemic
euglycemic clamp
& OGTT

35-65

46M/39F

Hispanic

Gulli et al.
1992

Normoglycemic

First-degree
relative

Hyperinsulinemic
euglycemic clamp
& OGTT

34-42

3M/18F

MexicanAmerican

Van Haeften et
al. 1998

Normoglycemic

First-degree
relative

44-47

8M/34F

White

Haffner et al.
1997

Normoglycemic
& Impaired
Glucose
Tolerance
Normoglycemic

First-degree
relative

Hyperglycemic
clamp
& OGTT
2-h OGTT

¯Glucose
tolerance
in FH+
¯ IS in FH+
No
Difference
in OGTT
¯ IS in FH+
No
Difference
¯Glucose
tolerance
in FH+

25-65

533M/743F

First-degree
relative

2-h OGTT

¯ IS in FH+

26-52

52M/36F

Normoglycemic
& Impaired
Glucose
Tolerance
Normoglycmic

First-degree
relative

2-h OGTT

¯Glucose
tolerance
in FH+

20+

First-degree
relative

2-h OGTT

¯ IS in FH+

16-60

71M/84F

NA

Osei et al.
1991

Normoglycemic

Family history of
diabetes

2-h OGTT
FSIVGTT

¯ IS in FH+

24-30

4M/16F

N/A

Wang et al.
2008

Normoglycemic
& Impaired
glucose
tolerance &
T2D
Normoglycemic

First-degree
relative

2-h OGTT
HOMA-IR

¯Glucose
tolerance
in FH+

31-65

183M/240F

Chinese

Relatives with
diabetes

HOMA-IR

¯ IS in FH+

18-68

66M/77F

Hispanic

Perseghin et
al. 1997

Ishikawa et al.
1998
Ramachandran
et al. 1997
Warram et al.
1990

Ryder et al.
2003

Family History

810M/936F

Race

Hispanics
&
African
Americans
White

Indian

Guerrero et al.
2005

Normoglycemic

Family history of
diabetes

HOMA-IR

¯ IS in FH+

18-24

18M/30F

White

Perez-Fuentes
et al. 2014

Normoglycemic

First-degree
relative

QUICKI

¯ IS in FH+

18-65

602 M&F

White
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Appendix B
Table 2. Literature Overview- Effects of family history of type 2 diabetes on insulin
sensitivity – sorted for Insulin Sensitivity Methodology
Author

Status

Method

Outcome
FH+ vs.
FHArslanian et Normoglycemic Hyperinsulinemic ¯ IS in FH+
al. 2005
euglycemic clamp

Age

Sex

Race

11-12

25M/29F

White

Petersen et Insulin resistant Hyperinsulinemic ¯ IS in FH+
al. 2004
&
euglycemic clamp
Insulin sensitive

19-36

8M/18F

Black
White

Perseghin Normoglycemic Hyperinsulinemic ¯ IS in FH+
et al. 1997
euglycemic clamp

19-41

28M/50F

Mexican

Groop et al. Normoglycemic
OGTT
¯Glucose
1996
Hyperinsulinemic tolerance in
euglycemic clamp
FH+
¯ IS in FH+
Gulli et al. Normoglycemic
OGTT
No
1992
Hyperinsulinemic Difference
euglycemic clamp in OGTT
¯ IS in FH+
Van
Normoglycemic
OGTT &
No
Haeften et
Hyperglycemic
Difference
al. 1998
clamp

35-65

46M/39F

Hispanic

34-42

3M/18F

MexicanAmerican

44-47

8M/34F

White

¯Glucose
tolerance in
FH+
¯Glucose
tolerance in
FH+

31-65

183M/240F

Chinese

26-52

52M/36F

White

Wang et al. Normoglycemic
2008

2-h OGTT

Ishikawa et Normoglycemic
al. 1998

2-h OGTT

Haffner et
al. 1997

Normoglycemic

2-h OGTT

¯Glucose
tolerance in
FH+

25-65

533M/743F

Osei et al. Normoglycemic
1991
Ryder et al. Normoglycemic
2003

2-h OGTT
FSIVGTT
HOMA-IR

¯ IS in FH+

24-30

4M/16F

Hispanics
&
African
Americans
N/A

¯ IS in FH+

18-68

66M/77F

Hispanic

Guerrero et Normoglycemic
al. 2005

HOMA-IR

¯ IS in FH+

18-24

18M/30F

White

QUICKI

¯ IS in FH+

18-65

602 M&F

White

PerezFuentes et
al. 2014

Normoglycemic
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¯Glucose
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2-h OGTT
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2-h OGTT
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White

PerezFuentes et
al. 2014
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Appendix C
Phone Interview
1.

Male?

2.

How would you describe your mother’s ethnicity?

3.

How would you describe your father’s ethnicity?

4.

What is your age?
Age: 18 ≤ Age ≤ 40 years? YES NO
DOB:

5.

To your knowledge, how would your fasting blood glucose be classified?
LOW NORMAL HIGH
Comments:

6.

What is your height? ___________cm

7.

What is your weight? ________kg

8.

(Tester calculate BMI) 18 ≤ BMI ≤ 30 kg/m2

9.

To your knowledge, how would your blood pressure be classified?
LOW NORMAL HIGH
Can you provide an estimated value? _________

10.

Do your parents have Type 2 Diabetes? (none, one parent, or both parents)
If so, which parent?

11.
12.

Do you exercise regularly? YES NO
Explain what type of exercise you perform and how many minutes per week you
spend doing these exercises.
Hyperlipidemia
73

To your knowledge, do you have high cholesterol? YES NO
To your knowledge, do you have high triglycerides? YES NO
Comments:
13.

Do you have any medical conditions or illnesses? YES NO
Comments:

14.

Are you currently taking any medications? YES NO
If so, what are they for?

15.

To your knowledge, has there been evidence supporting that you may have
cardiovascular disease or diabetes? YES NO
Comments:

16.

Are you currently taking any drugs that may affect your energy metabolism and
body weight? YES NO
Comments:

17.

Describe the frequency in which you:

1.
2.
3.
4.

Consume alcohol:
Use recreational drugs:
Smoke cigarettes or e-cigarettes:
Use chewing tobacco:
Comments:

5.

Do you currently have any type of eating disorder or eating attitudes that may
interfere with the study? YES NO
Comments:
Pass or Fail
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Comments:
Date & Time for Obtaining Signed Consent __________________
*Be sure to inform subject that they need to come FASTING when signing the consent
form
Accelerometer Applied _____________
Accelerometer Removed ____________
Accelerometer #: ___________
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Appendix D
1Repetition Maximum Protocol- HITD
1.
2.
3.

General Warm up for 5 minutes on treadmill- Slow paced jog.
Shoulder joint warm up. Arm circles forwards (20) & backwards (20).
20 horizontal arm abduction to adduction.
Specific warm up: Practice correct form execution with barbell.

1.
1.

Grip bar slightly wider than shoulder grip to ensure that forearms are
perpendicular to the ground once barbell is in contact with the chest at the
lowered position.
5 points of contact at all times
1.
2 feet
2.
Buttocks
3.
Back
4.
Head
ALWAYS PRACTICE PROPER SPOTING TECHNIQUE

2.
Bench press warm up sets

__________________ 40% of self-predicted 1 RM - 8 repetitions, 2-minute rest
__________________ 50% - 5 repetitions, 2-minute rest
__________________ 60% - 3 repetitions, 3-minute rest
Working set to 1Repetition Maximum
__________________ 80% - 1 repetition, 3-minute rest
__________________ 90% - 1 repetition, 3-minute rest
__________________ 100% - 1 repetition, 4-minute rest
__________________ 105% - 1 repetition
Back leg strength dynamometer
Warm up

1.
2.
3.

15 jumping jacks
Above the knee barbell deadlift pulls
2 practice pulls not to maximal effort

__________________ attempt 1, 3-minute rest
__________________ attempt 2, 3-minute rest
__________________ attempt 3, 3-minute rest
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Appendix F
Food Allergies

Please mark with an X if you are allergic to or if you dislike any of the
following foods and/or food components
FOOD
Allergic Dislike FOOD
Allergic Dislike
Apples
White rice
Avocados
Tortilla (corn)
Bananas
Corn taco shell
Melon
Flat whole wheat
(Cantaloupe)
bread
Melon
(Watermelon)
Whole wheat cereal
Strawberries
Eggs
Carrots medium
Low fat beef mince
Carrots small
Chicken breast fillet
Garlic
Margarine
Lettuce shredded
Peanut oil
Lettuce torn
leaves
Milk 2% fat
Mushrooms
medium
Cheddar cheese
Onions
Ice cream
Tomatoes cherry
Ground cinnamon
Tomatoes
Balsamic vinegar
Capsicum (Red
Seasoning mix, chilibell peppers)
based for tacos
Chili red
Oyster sauce
Rolled oats raw
Honey
Vegetarian refried
Mixed grain
bean (tomato, cumin,
bread
garlic, chili powder)
Water
Other
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Appendix G
Body Composition / Anthropometry

DOB:

AGE:
Trial 1

Trial 2

Trial 3

Average

Initials

Weight (kg)
Height (cm)
BMI (kg/m2)
Waist (cm)
Hips (cm)
WHR (cm)
Bod Pod
Total body weight (kg)
Fat mass (kg)
Lean mass (kg)
Body fat %
DXA
Total body weight (kg)
Fat mass (kg)
Lean mass (kg)
Body fat %
Bone mineral density
Comments: ________________________________________________
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Body Composition / Anthropometry
Measurement Units

Formula and Calculation

Kilograms and
meters (or
centimeters)

Formula: weight (kg) / [height (m)]2
With the metric system, the formula for BMI is weight in kilograms
divided by height in meters squared. Because height is commonly
measured in centimeters, divide height in centimeters by 100 to
obtain height in meters.
Example: Weight = 68 kg, Height = 165 cm (1.65 m)
Calculation: 68 ÷ (1.65)2 = 24.98

Pounds and inches

Formula: weight (lb) / [height (in)]2 x 703
Calculate BMI by dividing weight in pounds (lbs) by height in
inches (in) squared and multiplying by a conversion factor of 703.
Example: Weight = 150 lbs, Height = 5’5” (65”)
Calculation: [150 ÷ (65)2] x 703 = 24.96
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Appendix H
Physical Activity Recall questionnaire
Today's Date
Day (circle one): Mon
Thurs Fri Sat Sun
1. Were you employed in the last seven days?
0. No (Skip to Q#3)
2. If yes, which days?
Mon Tues Wed Thurs
3. What two days do you consider your weekend days? Mon Tues Wed Thurs

DAYS
1

2

3

4

Day: (mm/dd/yy)
Date:
Sleep:
In Bed / Up
Total time
Work:
Start / End
Total time

M
O
R
N
I
N
G

Moderate

Hard

Very Hard

Moderate

A
F
T
E
R
N
O
O
N

Hard

E
V
E
N
I
N
G

Hard

Very Hard

Moderate

Very Hard
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5

6

Tues

Wed

1. Yes
Fri Sat Sun
Fri Sat Sun

7

PAR Questionnaire – Page 2

4.

Compared to your physical activity over the past three months, was last week's
physical activity more, less or about the same?
1. More
2. Less
3. About the same

KEY

Rounding: 10-22 min
=
0.25 hr
Place asterisk (*) to the right of a work-related activity
2337 min
=
0.50 hr
& the time spent doing it.
38-52 min
=
0.75 hr
53-1:07 hr:min =
1.0 hr
1:08-1:22 hr:min =
1.25 hr

INTERVIEWER:
Please answer questions below and note any comments on interview.
5. Were there any problems with the 7-Day PAR interview? 0. No
1. Yes (If yes, please
explain.)

6. Do you think this was a valid 7-Day PAR interview?
explain)

0.
1. Yes
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No

(Please

1.

Please list below any activities reported by the subject that you don't know how to
classify.

8. Please provide any other comments you may have in the space below.

SEVEN-DAY PHYSICAL ACTIVITY RECALL (PAR) LIST OF ACTIVITIES
Intensity
Job
Home
Sport or Recreation
****************************************************************************************************
************
* Typing
* Ironing, sewing
* Leisurely walking
LIGHT
* Standing
* Light auto repair
* Softball
* Driving
* Indoor Painting
* Bowling
* Playing a musical
instrument
****************************************************************************************************
************
* Lifting or carrying
* Sweeping, Mopping,
* Brisk walking (on
level ground)
light objects
Vacuuming
* Shooting baskets
(up to 5 lbs)
* Clipping hedges
* Throwing frisbee
MODERATE
* Raking
* Cycling leisurely
* Mowing lawn with
on level ground
* Painting outpower mower
* Swimming laps
(easy effort)
side of house
* Cleaning windows
* Weightlifting
83

* Pushing stroller
with child
****************************************************************************************************
************
* Construction work
* Scrubbing floors
* Brisk walking
(uphill)
* Lifting or
* Shoveling dirt, coal, etc. * Backpacking (on
level ground)
carrying objects
* Mowing lawn with
* Brisk cycling on
level ground
HARD
(5-15 lbs)
non-power mower
without losing
breath
* Climbing
* Carrying child
* Tennis (doubles)
ladder or stairs
(5-15 lbs)
* Downhill skiing
* Swimming laps
(moderate
effort)
****************************************************************************************************
************
* Carrying heavy
* Digging ditches
* Jogging
loads such as
* Chopping or
* Basketball (in
game)
bricks or lumber
splitting wood
* Soccer (in game)
* Gardening with
* Backpacking (uphill)
VERY
* Carrying
heavy tools
* Cycling (uphill or
racing)
HARD
moderate loads
* Tennis (singles)
upstairs
* Cross-country
skiing
(16-40 lbs)
* Swimming laps
(hard effort)
* Aerobic dancing
* Circuit training
(using a series
of Nautilus
machines without
stopping)
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Appendix I
Accelerometer Instructions
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.

Put the accelerometer on using the elastic band and make sure it is close to your
hip bone.
Ensure the monitor is worn upright (the black circular cap should be on top).
Ensure the monitor is worn on the RIGHT side of the body.
Wear the unit day and night until the scheduled return date.
Use caution when undressing to avoid dropping the unit on the floor.
Do not expose to water or extreme temperatures.
Remove it only to bathe or shower (place unit on your towel to remind you to
reapply it immediately after dressing).
Avoid swimming during your scheduled time to wear the unit. If swimming would
normally be a significant part of your activity during this period notify the staff of
this fact.
Please DO NOT lose it.
Wear the unit until your next visit.

85

Appendix J

5 Day Menu- Dietary meal plan
McAinch & Bajpeyi
10500kj or 2500kcal
Gender , Age (years), Weight (kg), Height (cm), Sedentary Activity

Day Meal

Food

Quantity

Note

Day 1
Breakfast
Oats,rolled,raw
80g
Milk,cow,fluid,reduced fat
480 mL
(~1.5%),increased
calcium,added vitamins A & D
Banana,cavendish,peeled,raw 1 medium (12-17cm
long)
Cinnamon,ground
1 tsp

1 cup
2 cups

lunch
Bread,from wholemeal
flour,added fibre
Lettuce,cos,raw

4 slice
0.25 cup
(shredded/chopped)
1.5 medium (6-8cm dia)

Tomato,common,raw

Sliced
circularly
Cheese,cheddar,reduced fat 1.65 slice (pre packed) 1/2 cup
(~ 25%)
Mushroom,common,raw
4 medium
Sliced
vertically
Carrot,mature,peeled,raw
1 medium (17cm long) Shreded
for salad
Margarine
26g
2 tbsp
spread,polyunsaturated (70%
fat),sodium = 360 mg/100
g,added vitamin E
Capsicum,red,raw
0.5 medium Sliced
dinner
Vegetarian refried beans
Tortilla,from corn flour
Rice,white,boiled without
added salt
Tomato,common,raw

1 Serveing (1 CUP)
1 Medium (~15cm dia)
1 cup (cooked)
1.5 medium (6-8cm dia)
Sliced circularly
0.5 cup (torn leaves)

Lettuce,cos,raw
86

Avocado,hass,raw
Vinegar
Capsicum,red,raw

0.25 avocado
1 tb
0.5 medium

Carrot,mature,peeled,raw

1 small (14cm long)

Margarine
19g
spread,polyunsaturated (70%
fat),sodium = 360 mg/100
g,added vitamin E

Sliced
vertically
Shredde
d for
salad
1.5 tbsp

snack
Melon,watermelon,peeled,raw 300g
Strawberry,fresh,raw

100g

Melon,rockmelon
(cantaloupe),peeled,raw

100g

Ice cream,reduced fat,vanilla 1 cup
& other non-chocolate
flavours
Banana,cavendish,peeled,raw 1 medium (12-17cm
long)
Water,tap
1.5 L
Apple,granny
1 apple
smith,unpeeled,raw
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Cut to
1”
squares
Remove
stem
Cut to
1”
squares

Day 2

Breakfast
Oats,rolled,raw
80g
Milk,cow,fluid,reduced fat
480 mL
(~1.5%),increased
calcium,added vitamins A & D
Banana,cavendish,peeled,raw 1 medium (12-17cm
long)
Honey
2.5 tb

1 cup
2 cups

lunch
Vegetarian refried beans
Tortilla,from corn flour

1 Serve
56g

only 10mg
sodium not
425mg but
balanced
out
with
other
products

Lettuce,cos,raw

0.25 cup
(shredded/chopped)
Tomato,common,raw
1.5 medium (6-8cm
Sliced
dia)
Cheese,cheddar,reduced fat 1.65 slice (pre
1/2 cup
(~ 25%)
packed)
Mushroom,common,raw
4 medium
Sliced
Carrot,mature,peeled,raw
1 medium (17cm long) Shreded
Avocado,hass,raw
0.25 avocado
Margarine
19g
1.5 tbsp
spread,polyunsaturated (70%
fat),sodium = 360 mg/100
g,added vitamin E
Egg,chicken,whole,raw
1 egg; large, Edible
portion from 50 g egg
Capsicum,red,raw
0.5 medium
Sliced
dinner
Beef,mince,low fat,raw
56.7g
2 ounces
Taco shell,from corn
2 regular (12.5cm dia)
flour,plain
Onion,mature,peeled,raw,nfs 0.25 medium (6cm
Sliced
dia)
Seasoning mix,chilli-based,for 5g
tacos
Tomato,common,raw
1.5 medium (6-8cm
Sliced
dia)
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Lettuce,cos,raw
Capsicum,red,raw
Carrot,mature,peeled,raw
Bread,flat (pita/lebanese
style),wholemeal
Margarine
spread,polyunsaturated (70%
fat),sodium = 360 mg/100
g,added vitamin E

0.5 cup (torn leaves)
0.5 medium
1 small (14cm long)
86g

2 rolls

13g

1tbsp

Sliced

snack
Melon,watermelon,peeled,raw 300g
Strawberry,fresh,raw

150g

Melon,rockmelon
100g
(cantaloupe),peeled,raw
Banana,cavendish,peeled,raw 1 medium (12-17cm
long)
Water,tap
1.5 L
Apple,granny
1 apple
smith,unpeeled,raw
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Cut to 1”
squares
Remove
stem
Cut to 1”
squares

Day 3
Breakfast
Oats,rolled,raw
80g
Milk,cow,fluid,reduced fat
480 mL
(~1.5%),increased
calcium,added vitamins A & D
Banana,cavendish,peeled,raw 1 medium (1217cm long)
Cinnamon,ground
1 tsp

1 cup
2 cups

Beef,mince,low fat,raw
Onion,mature,peeled,raw,nfs

56.7g
0.25 medium
(6cm dia)
Seasoning mix,chilli-based,for 5g
tacos
Tomato,common,raw
1.5 medium (68cm dia)
Lettuce,cos,raw
0.5 cup (torn
leaves)
Capsicum,red,raw
0.5 medium
Cheese,cheddar,reduced fat (~ 0.825 slice (pre
25%)
packed)
Carrot,mature,peeled,raw
1 small (14cm
long)
Bread,flat (pita/lebanese
86g
style),wholemeal
Margarine
26g
spread,polyunsaturated (70%
fat),sodium = 360 mg/100
g,added vitamin E

2 ounces
Sliced

Vegetarian refried beans
Tortilla,from corn flour

1 Cup
only 10mg
sodium not
425mg but
balanced out
with other
products

lunch

Sliced

Sliced
1/4 cup
Shreded
2 rolls
2tbsp

dinner
1 Serve
56g

Rice,white,boiled without added 1 cup (cooked)
salt
Tomato,common,raw
1.5 medium (68cm dia)
Lettuce,cos,raw
0.5 cup (torn
leaves)
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Sliced

Avocado,hass,raw
Vinegar
Capsicum,red,raw
Carrot,mature,peeled,raw
Margarine
spread,polyunsaturated (70%
fat),sodium = 360 mg/100
g,added vitamin E

0.25 avocado
1 tb
0.5 medium
1 small (14cm
long)
26g

Sliced
Shreded
2tbsp

snack
Melon,watermelon,peeled,raw 300g
Strawberry,fresh,raw
Melon,rockmelon
(cantaloupe),peeled,raw
Ice cream,reduced fat,vanilla &
other non-chocolate flavours
Banana,cavendish,peeled,raw
Water,tap
Apple,granny
smith,unpeeled,raw
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100g
200g
0.66 cup
1 medium (1217cm long)
1.5 L
1 apple

Cut to 1”
squares
Remove stem
Cut to 1”
squares

Day 4

Breakfast
Oats,rolled,raw
80g
Milk,cow,fluid,reduced fat 480 mL
(~1.5%),increased
calcium,added vitamins A &
D
Banana,cavendish,peeled,r 1 medium (12-17cm
aw
long)
Honey
1 tb

1 cup
2 cups

lunch
Bread,from wholemeal
flour,added fibre
Lettuce,cos,raw

4 slice

Tomato,common,raw
Cheese,cheddar,reduced
fat (~ 25%)
Mushroom,common,raw
Carrot,mature,peeled,raw
Margarine
spread,polyunsaturated
(70% fat),sodium = 360
mg/100 g,added vitamin E
Egg,chicken,whole,raw

0.25 cup
(shredded/chopped)
1.5 medium (6-8cm dia)
1.65 slice (pre packed) 1/2 cup
4 medium
Sliced
1 medium (17cm long) Shreded
26g
2tbsp

1 egg; large, Edible
portion from 50 g egg

dinner
Beef,mince,low fat,raw

56.7g

Taco shell,from corn
flour,plain
Onion,mature,peeled,raw,n
fs
Seasoning mix,chillibased,for tacos
Tomato,cherry,raw
Lettuce,cos,raw
Capsicum,red,raw
Carrot,mature,peeled,raw

2 regular (12.5cm dia)

Bread,flat (pita/lebanese
style),wholemeal

2
ounces

0.25 medium (6cm dia) Sliced
5g
1 cup (cherry tomato)
0.5 cup (torn leaves)
1 medium
1 small (14cm long)
86g
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Sliced
Shreded
2 rolls

Margarine
26g
spread,polyunsaturated
(70% fat),sodium = 360
mg/100 g,added vitamin E

2tbsp

Melon,watermelon,peeled,r 300g
aw
Strawberry,fresh,raw
150g

Cut to 1”
squares
Remove
stem
Cut to 1”
squares

snack

Melon,rockmelon
200g
(cantaloupe),peeled,raw
Banana,cavendish,peeled,r 1 medium (12-17cm
aw
long)
Water,tap
1.5 L
Apple,granny
1 apple
smith,unpeeled,raw
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Day 5

Breakfast
Oats,rolled,raw
80g
1 cup
Milk,cow,fluid,reduced fat
480 mL
2 cups
(~1.5%),increased
calcium,added vitamins A & D
Banana,cavendish,peeled,raw 1 medium (12-17cm
long)
Cinnamon,ground
1 tsp
lunch
Bread,from wholemeal
flour,added fibre
Lettuce,cos,raw

4 slice

0.25 cup
(shredded/chopped)
Tomato,common,raw
1.5 medium (6-8cm
dia)
Cheese,cheddar,reduced fat (~ 0.85 slice (pre
25%)
packed)
Mushroom,common,raw
4 medium
Carrot,mature,peeled,raw
1 medium (17cm
long)
Margarine
26g
spread,polyunsaturated (70%
fat),sodium = 360 mg/100
g,added vitamin E

Sliced
1/4 cup
Sliced
Sliced
2tbsp

dinner
Chicken,breast,lean,raw
Rice,white,boiled without
added salt
Capsicum,red,raw
Carrot,mature,peeled,raw

0.5 fillet; yeild after
skin and fat removed
1.5 cup (cooked)

1 medium
Sliced
1 small (14cm long)
Shredded
Onion,mature,peeled,raw,nfs 0.25 medium (6cm Sliced
dia)
Mushroom,common,raw
4 medium
Sliced
Chilli (chili),red,raw
2 chilli
Whole
Sauce,oyster,Asian,commercia 3 tsp
In zip
l
lock bag
Garlic,peeled,raw
1 clove
Oil,peanut
2 tsp
Broccoli,fresh,raw
100g
Margarine
26g
2tbsp
spread,polyunsaturated (70%
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fat),sodium = 360 mg/100
g,added vitamin E
Tomato,cherry,raw

1 cup (cherry
tomato)

snack
Melon,watermelon,peeled,raw 300g
Strawberry,fresh,raw

100g

Melon,rockmelon
200g
(cantaloupe),peeled,raw
Ice cream,reduced fat,vanilla & 0.5 cup
other non-chocolate flavours
Banana,cavendish,peeled,raw 1 medium (12-17cm
long)
Water,tap
1.5 L
Apple,granny
1 apple
smith,unpeeled,raw
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Cut to 1”
squares
Remove
stem
Cut to 1”
squares

Appendix K
VO2 MAX
Weight (kg):
DOB:
Staff Initials:
Height (cm):
Age Predicted Max HR (bpm)208-(0.7xa ge ) :
Resting VO2 Values: L/min
ml/kg/min
Stage
Ti me (mi n)
L/min ml/kg/min HR (bpm)
1

Resting
VO2

2
3
4
5

Stage
Ti me (mi n)
Speed
Warm up
1
3.5 mph
Warm up
2
3.5 mph
Warm up
3
3.5 mph
4
5 mph
5
5 mph
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
Recovery
1
3 mph
Recovery
2
3 mph
Recovery
3
3 mph
Recovery
4
3 mph
Recovery
5
3 mph

Incline
3%
3%
3%
0
0
1%
2%
3%
4%
5%
6%
7%
8%
9%
10%
11%
12%
13%
14%
15%
0
0
0
0
0
VO2M:
HRM:
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HR (bpm)

RPE

VO2

Vo2 Max Criteria

Achieved (Yes/No)

Value

Plateau reached
Peak RER ≥ 1.1
Max heart rate reached
RPE ≥ 17
Total number of criteria met

/4

VO2max achieved with a
minimum of 2/4 criteria met
(circle one)

Yes
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NO

Appendix L
Oral Glucose Tolerance Test (OGTT)
Instructions:
1.
Explain procedure to patient.
2.
Take a blood sample and measure fasting glucose two times.
3.
Give 75 grams of glucose drink.
4.
Collect blood samples at indicated time intervals and record value two times.

Time frame

Time

Trail 1

Trial 2

Average

Fasting glucose
15 minutes
30 minutes
60 minutes
90 minutes
120 minutes
150 minutes
180 minutes

Comments:
____________________________________________________________
____________________________________________________________
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